<SEC-DOCUMENT>0001193125-24-170947.txt : 20240628
<SEC-HEADER>0001193125-24-170947.hdr.sgml : 20240628
<ACCEPTANCE-DATETIME>20240627213054
ACCESSION NUMBER:		0001193125-24-170947
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240626
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240628
DATE AS OF CHANGE:		20240627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Addus HomeCare Corp
		CENTRAL INDEX KEY:			0001468328
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOME HEALTH CARE SERVICES [8082]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				205340172
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34504
		FILM NUMBER:		241081113

	BUSINESS ADDRESS:	
		STREET 1:		6303 COWBOYS WAY
		STREET 2:		SUITE 600
		CITY:			FRISCO
		STATE:			TX
		ZIP:			75034
		BUSINESS PHONE:		469-535-8200

	MAIL ADDRESS:	
		STREET 1:		6303 COWBOYS WAY
		STREET 2:		SUITE 600
		CITY:			FRISCO
		STATE:			TX
		ZIP:			75034
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d805293d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:adus="http://www.addus.com/20240626" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-06-26_to_2024-06-26">Addus HomeCare Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-316">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-06-26_to_2024-06-26">0001468328</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="adus-20240626.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-06-26_to_2024-06-26"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001468328</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-06-26</xbrli:startDate> <xbrli:endDate>2024-06-26</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-327">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): June&#160;28, 2024 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt:datemonthdayyearen" id="ixv-328">June 26, 2024</ix:nonNumeric>)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">ADDUS HOMECARE CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:stateprovnameen" id="ixv-329">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-330">001-34504</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-331">20-5340172</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-332">6303 Cowboys Way</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-333">Suite 600</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-334">Frisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:stateprovnameen" id="ixv-335">Texas</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-336">75034</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-337">(469)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-338">535-8200</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-339">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-340">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-341">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-</span> 2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-342">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-</span> 4(c))</p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-343">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-344">ADUS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:exchnameen" id="ixv-345">The Nasdaq Stock Market, LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company.&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-06-26_to_2024-06-26" format="ixt-sec:boolballotbox" id="ixv-346">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;26, 2024, Addus HomeCare Corporation, a Delaware corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with BofA Securities, Inc. and Jefferies LLC, acting as representatives of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), relating to an underwritten public offering (the &#8220;Offering&#8221;) of 1,500,000 shares (the &#8220;Firm Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at a price to the public of $108.00 per share before deducting underwriting discounts and commissions. Pursuant to the Underwriting Agreement, the Company granted the Underwriters a <span style="white-space:nowrap">30-day</span> option to purchase up to an additional 225,000 shares of Common Stock (the &#8220;Option Shares&#8221;) on the same terms as the Firm Shares.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimates that the net proceeds from the Offering will be approximately $153&#160;million, or approximately $176&#160;million if the Underwriters exercise in full their option to purchase the Option Shares, in each case after deducting underwriting discounts and commissions. The Company intends to use approximately $81.4&#160;million of the net proceeds it receives from the Offering for the repayment of all indebtedness outstanding under its credit facility and the remainder for general corporate purposes, including the Company&#8217;s previously announced acquisition of the personal care assets of Gentiva and any future acquisitions or investments. There were no selling stockholders in the offering. The closing of the Offering is expected to occur on or about June&#160;28, 2024, subject to customary closing conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Offering is being conducted pursuant to an effective registration statement on <span style="white-space:nowrap">Form&#160;S-3ASR</span> (Registration <span style="white-space:nowrap">No.&#160;333-267253)</span> and a related prospectus and prospectus supplement, in each case filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains customary representations, warranties and covenants by the Company, as well as customary indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act, other obligations of the parties and termination provisions. In addition, subject to certain exceptions, the Company and its officers and directors have agreed not to sell or otherwise dispose of any of the shares of Common Stock or securities convertible into or exchangeable or exercisable for any shares of Common Stock held by them for a period ending 60 days after the date of the Underwriting Agreement without first obtaining the written consent of BofA Securities, Inc. and Jefferies LLC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement has been filed as an exhibit hereto. It is not intended to provide any other factual information about the Company. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of the Underwriting Agreement and as of specific dates, were solely for the benefit of the parties to the Underwriting Agreement, and may be subject to limitations agreed upon by the contracting parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is filed as Exhibit&#160;1.1 to this Current Report and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the legal opinion and consent of Bass Berry&#160;&amp; Sims PLC, counsel to the Company, with respect to the legality of the issuance and sale of the Firm Shares and the Option Shares in the Offering is filed as Exhibit&#160;5.1 to this Current Report and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued two press releases on June&#160;26, 2024, announcing the commencement and pricing of the Offering, respectively. A copy of the press releases are filed herewith as Exhibits 99.1 and 99.2, respectively, to this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> and are each incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Description</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d805293dex11.htm">Underwriting Agreement dated June&#160;26, 2024 by and among the Company, BofA Securities, Inc. and Jefferies LLC, as representatives of the several Underwriters listed on Schedule A thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d805293dex51.htm">Opinion of Bass Berry&#160;&amp; Sims PLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d805293dex51.htm">Consent of Bass Berry&#160;&amp; Sims PLC (included in Exhibit&#160;5.1) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d805293dex991.htm">Press Release, dated June&#160;26, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d805293dex992.htm">Press Release, dated June&#160;26, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">ADDUS HOMECARE CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;28, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Poff</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Brian Poff</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d805293dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1,500,000 Shares </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Addus
HomeCare Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">June&nbsp;26, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JEFFERIES LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As Representatives of the several
Underwriters </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Bryant Park
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o JEFFERIES LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">520 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Introductory.</B>
Addus HomeCare Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to issue and sell to the several underwriters named in <U>Schedule A</U> (the &#147;<B>Underwriters</B>&#148;) an aggregate of 1,500,000 shares (the
&#147;<B>Firm Shares</B>&#148;) of its common stock, par value $0.001 per share (the &#147;<B>Shares</B>&#148;). In addition, the Company has granted the Underwriters an option to purchase up to an additional 225,000 Shares (the &#147;<B>Optional
Shares</B>&#148;), as provided in Section&nbsp;2. The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the &#147;<B>Offered Shares</B>.&#148; BofA Securities, Inc. (&#147;<B>BofA</B>&#148;)
and Jefferies LLC (&#147;<B>Jefferies</B>&#148;) agreed to act as representatives of the several Underwriters (in such capacity, the &#147;<B>Representatives</B>&#148;) in connection with the offering and sale of the Offered Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made herein to the planned acquisition (the &#147;<B>Acquisition</B>&#148;) by the Company of the personal care business of Curo
Health Services, LLC (&#147;<B>Gentiva</B>&#148;), consisting of (A)&nbsp;all of the outstanding equity interests of (i)&nbsp;IntegraCare of Abilene, LLC (&#147;<B>IntegraCare</B>&#148;), (ii) NP Plus, LLC (&#147;<B>NP Plus</B>&#148;), (iii) Girling
Health Care Services of Knoxville, Inc. (&#147;<B>Girling Knoxville</B>&#148;), and (iv)&nbsp;Girling Health Care, Inc., (&#147;<B>Girling Texas</B>,&#148; and together with Girling Knoxville, NP Plus and IntegraCare, the &#147;<B>Transferred
Subsidiaries</B>&#148;) and (B)&nbsp;certain assets and liabilities of (i)&nbsp;Central Arizona Home Health Care, Inc., Community Home Care&nbsp;&amp; Hospice, LLC, TNMO Healthcare, LLC, and Odyssey HealthCare Operating A, LP, pursuant to that
certain stock and asset purchase agreement by and between Addus Healthcare, Inc. and Gentiva, dated June&nbsp;8, 2024 (together with the exhibits and schedules thereto, as amended, supplemented or otherwise modified, the &#147;<B>Acquisition
Agreement</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has prepared and filed with the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;)
a shelf registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,</FONT> File <FONT STYLE="white-space:nowrap">No.&nbsp;333-267253,</FONT> including a base prospectus (the &#147;<B>Base Prospectus</B>&#148;) to be used in connection
with the public offering and sale of the Offered Shares. Such registration statement, as amended, including the financial statements, exhibits and schedules thereto, in the form in which it became effective under the Securities Act of 1933, as
amended, and the rules and regulations promulgated thereunder (collectively, the &#147;<B>Securities Act</B>&#148;), including all documents incorporated or deemed to be incorporated by reference therein and any information deemed to
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be a part thereof at the time of effectiveness pursuant to Rule&nbsp;430A or 430B under the Securities Act, is called the &#147;<B>Registration Statement</B>.&#148; Any registration statement
filed by the Company pursuant to Rule 462(b) under the Securities Act in connection with the offer and sale of the Offered Shares is called the &#147;<B>Rule 462(b) Registration Statement</B>,&#148; and from and after the date and time of filing of
any such Rule 462(b) Registration Statement the term &#147;Registration Statement&#148; shall include the Rule 462(b) Registration Statement. The preliminary prospectus supplement dated June&nbsp;26, 2024 describing the Offered Shares and the
offering thereof (the &#147;<B>Preliminary Prospectus Supplement</B>&#148;), together with the Base Prospectus, is called the &#147;<B>Preliminary Prospectus</B>,&#148; and the Preliminary Prospectus and any other prospectus supplement to the Base
Prospectus in preliminary form that describes the Offered Shares and the offering thereof and is used prior to the filing of the Prospectus (as defined below), together with the Base Prospectus, is called a &#147;<B>preliminary prospectus</B>.&#148;
As used herein, the term &#147;<B>Prospectus</B>&#148; shall mean the final prospectus supplement to the Base Prospectus that describes the Offered Shares and the offering thereof (the &#147;<B>Final Prospectus Supplement</B>&#148;), together with
the Base Prospectus, in the form first used by the Underwriters to confirm sales of the Offered Shares<B> </B>or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under the
Securities Act. References herein to the Preliminary Prospectus, any preliminary prospectus and the Prospectus shall refer to both the prospectus supplement and the Base Prospectus components of such prospectus. As used herein, &#147;<B>Applicable
Time</B>&#148; is 6:30 p.m. (New York City time) on June&nbsp;26, 2024. As used herein, &#147;<B>free writing prospectus</B>&#148; has the meaning set forth in Rule 405 under the Securities Act, and &#147;<B>Time of Sale Prospectus</B>&#148; means
the Preliminary Prospectus, as amended or supplemented immediately prior to the Applicable Time, together with the free writing prospectuses, if any, identified in <U>Schedule C</U> hereto. As used herein, <B>&#147;Road Show&#148;</B> means a
&#147;road show&#148; (as defined in Rule 433 under the Securities Act) relating to the offering of the Offered Shares contemplated hereby that is a &#147;written communication&#148; (as defined in Rule 405 under the Securities Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All references in this Agreement to the Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus
and the Prospectus shall include the documents incorporated or deemed to be incorporated by reference therein. All references in this Agreement to financial statements and schedules and other information which are &#147;contained,&#148;
&#147;included&#148; or &#147;stated&#148; in, or &#147;part of&#148; the Registration Statement, the Rule 462(b) Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus, the Time of Sale Prospectus or the
Prospectus, and all other references of like import, shall be deemed to mean and include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Rule
462(b) Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus, the Time of Sale Prospectus or the Prospectus, as the case may be. All references in this Agreement to amendments or supplements to the
Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus, the Time of Sale Prospectus or the Prospectus shall be deemed to mean and include the filing of any document under the Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated thereunder (collectively, the &#147;<B>Exchange Act</B>&#148;) that is or is deemed to be incorporated by reference in the Registration Statement, the Preliminary Prospectus, any
preliminary prospectus, the Base Prospectus, or the Prospectus, as the case may be. All references in this Agreement to (i)&nbsp;the Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus or the
Prospectus, any amendments or supplements to any of the foregoing, or any free writing prospectus, shall include any copy thereof filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System
(&#147;<B>EDGAR</B>&#148;) and (ii)&nbsp;the Prospectus shall be deemed to include any &#147;electronic Prospectus&#148; provided for use in connection with the offering of the Offered Shares as contemplated by Section&nbsp;3A(o) of this Agreement.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby confirms its agreement with the Underwriters as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. Representations and Warranties of the Company. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A. </B><B><I>Representations and Warranties of the Company</I></B><B>. </B>The Company hereby represents, warrants and covenants to each
Underwriter, as of the date of this Agreement, as of the First Closing Date (as hereinafter defined) and as of each Option Closing Date (as hereinafter defined), if any, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><I>Compliance with Registration Requirements</I></B><B>.</B> The Registration Statement has become effective under the Securities
Act. The Company has complied with all requests of the Commission for additional or supplemental information, if any. No stop order suspending the effectiveness of the Registration Statement is in effect and no proceedings for such purpose have been
instituted or are pending or, to the knowledge of the Company, are contemplated or threatened by the Commission. At the time the Registration Statement was filed with the Commission, at the time any post-effective amendment to the Registration
Statement was filed, and at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Securities Act) made any <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the
Securities Act) relating to the Offered Shares in reliance on the exemption of Rule 163 under the Securities Act, the Company was a &#147;well known seasoned issuer&#148; as defined in Rule 405 under the Securities Act. The Registration Statement is
an &#147;automatic shelf registration statement,&#148; as defined in Rule 405 under the Securities Act, and became effective on September&nbsp;2, 2022. The Company has not received from the Commission any notice pursuant to Rule 401(g)(2) under the
Securities Act objecting to the Company&#146;s use of the automatic shelf registration form. The Company meets the requirements for use of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act specified in the Financial Industry
Regulatory Authority, Inc. (&#147;<B>FINRA</B>&#148;) Rule 5110(h)(1)(C) and is an experienced issuer (as defined in FINRA Rule 5110(j)(6)). The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Time
of Sale Prospectus and the Prospectus, at the time they were or hereafter are filed with the Commission, or became effective under the Exchange Act, as the case may be, complied and will comply in all material respects with the requirements of the
Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><I>Disclosure</I></B><B>.</B> Each preliminary prospectus and the Prospectus when filed complied in all
material respects with the Securities Act and, if filed by electronic transmission pursuant to EDGAR, was identical (except as may be permitted by <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-T</FONT> under the Securities Act) to the copy
thereof delivered to the Underwriters for use in connection with the offer and sale of the Offered Shares. Each of the Registration Statement and any post-effective amendment thereto, at the time it became or becomes effective, complied and will
comply in all material respects with the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading. As of the Applicable Time, the Time of Sale Prospectus did not, and at the First Closing Date (as defined in Section&nbsp;2) and at each applicable Option Closing Date (as defined in Section&nbsp;2), will not, contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Prospectus, as of its date, did not, and at the First Closing
Date and at each applicable Option Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The representations and warranties set forth in the three immediately preceding sentences do not apply to statements in or omissions from the Registration Statement or any post-effective amendment thereto, or the Prospectus or
the Time of Sale Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with written information relating to any Underwriter furnished to the Company in writing by the Representatives expressly for use therein,
it being understood and agreed that the only such information consists of the information described in Section&nbsp;9(c) below. There are no contracts or other documents required to be described in the Time of Sale Prospectus or the Prospectus or to
be filed as an exhibit to the Registration Statement which have not been described in all material respects or filed as required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B><I>Free Writing Prospectuses; Road Show</I></B><B>.</B> As of the
determination date referenced in Rule 164(h) under the Securities Act, the Company was not, is not or will not be (as applicable) an &#147;ineligible issuer&#148; in connection with the offering of the Offered Shares pursuant to Rules 164, 405 and
433 under the Securities Act. Each free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities
Act. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all
material respects with the requirements of Rule 433 under the Securities Act, including timely filing with the Commission, retention and legending, as applicable, and each such free writing prospectus, as of its issue date and at all subsequent
times through the completion of the public offer and sale of the Offered Shares did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the
Prospectus or any preliminary prospectus unless such information has been superseded or modified as of such time. Except for the free writing prospectuses, if any, identified in <U>Schedule C</U>, and electronic road shows, if any, furnished to the
Representatives before first use, the Company has not prepared, used or referred to, and will not, without the prior written consent of the Representatives, prepare, use or refer to, any free writing prospectus. Each Road Show, when considered
together with the Time of Sale Prospectus, did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B><I>Distribution of Offering Material </I></B><B><I>By</I></B><B><I> the
Company</I></B><B>.</B> Prior to the later of (i)&nbsp;the expiration or termination of the option granted to the several Underwriters in Section&nbsp;2 and (ii)&nbsp;the completion of the Underwriters&#146; distribution of the Offered
Shares<B>,</B> the Company has not distributed and will not distribute any offering material in connection with the offering and sale of the Offered Shares other than the Registration Statement, the Time of Sale Prospectus, the Prospectus or any
free writing prospectus reviewed and consented to by the Representatives, if any, identified on <U>Schedule C</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)
</B><B><I>The Underwriting Agreement</I></B><B>.</B> This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) </B><B><I>Authorization of the Offered Shares</I></B><B>.</B> The Offered Shares have been duly authorized for issuance and sale
pursuant to this Agreement and, when issued and delivered by the Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and the issuance and sale of the Offered Shares is not subject to any
preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase the Offered Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) </B><B><I>No
Applicable Registration or Other Similar Rights</I></B><B>.</B> There are no persons with registration or other similar rights to have any equity or debt securities registered for sale under the Registration Statement or included in the offering
contemplated by this Agreement, except for such rights as have been duly waived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h) </B><B><I>No Material Adverse
Change</I></B><B>.</B> Except as otherwise disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, subsequent to the respective dates as of which information is given in the Registration Statement, the Time of Sale
Prospectus and the Prospectus: (i)&nbsp;there has been no material adverse change, or any development that would reasonably be expected to result in a material adverse change, in (A)&nbsp;the condition, financial or otherwise, or in the earnings,
business, properties, operations, assets, liabilities or prospects, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered as one entity or (B)&nbsp;the ability of the Company to
consummate the transactions contemplated by this Agreement or perform its obligations hereunder (any such change being referred to herein as a &#147;<B>Material Adverse Change</B>&#148;); (ii)&nbsp;the Company and its subsidiaries, considered as one
entity, have not incurred any material liability or obligation, indirect, direct or contingent, including without limitation any losses or interference with their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or
decree, that are material, individually or in the aggregate, to the Company and its subsidiaries, considered as one entity, and have not entered into any transactions not in the ordinary course of business; and (iii)&nbsp;there has not been any
material decrease in the capital stock or any material increase in any short-term or long-term indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company or,
except for dividends paid to the Company or other subsidiaries, by any of the Company&#146;s subsidiaries on any class of capital stock, or any repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>) </B><B><I>Independent Accountants</I></B><B>.</B> PricewaterhouseCoopers LLP, which has expressed its opinion with
respect to the financial statements (which term as used in this Agreement includes the related notes thereto) and supporting schedules filed with the Commission and incorporated by reference as a part of the Registration Statement, the Time of Sale
Prospectus and the Prospectus, is an independent registered public accounting firm with respect to the Company as required by the Securities Act, and the rules of the Public Company Accounting Oversight Board (&#147;<B>PCAOB</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j) </B><B><I>Financial Statements</I></B><B>.</B> The financial statements filed with the Commission and incorporated by reference as a
part of the Registration Statement, the Time of Sale Prospectus and the Prospectus present fairly in all material respects the consolidated financial position of the Company as of the dates indicated and the results of their operations, changes in
stockholders&#146; equity and cash flows for the periods specified. The supporting schedules included in the Registration Statement present fairly in all material respects the information required to be stated therein. Such financial statements and
supporting schedules have been prepared in conformity with generally accepted accounting principles as applied in the United States (&#147;<B>GAAP</B>&#148;) applied on a consistent basis throughout the periods involved, except as may be expressly
stated in the related notes thereto. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been
prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. The other financial data regarding the Company or Gentiva included or incorporated by reference in the Registration Statement, the Time of Sale Prospectus and
the Prospectus present fairly, in all material respects, the information shown therein and such data has been compiled on a basis consistent with the financial statements presented therein and the books and records of the Company or Gentiva, as
applicable. The Company does not have any material liabilities or obligations, direct or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations or any &#147;variable interest entities&#148; within the meaning
of Financial Accounting Standards Board Interpretation No.&nbsp;46), not disclosed in the Registration Statement, the Time of Sale prospectus and the Prospectus, other than such liabilities and obligations that where incurred in the ordinary course
of business. No other financial statements or supporting schedules are required to be included in the Registration Statement, the Time of Sale Prospectus or the Prospectus. All disclosures contained or incorporated by reference in the Registration
Statement, any preliminary prospectus, the Prospectus and any free writing prospectus that constitute <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures (as defined by the rules and regulations under the Securities Act and the
Exchange Act) comply with Regulation G under the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, as applicable. To the Company&#146;s knowledge, no person who has been suspended or barred
from being associated with a registered public accounting firm, or who has failed to comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or otherwise aided the preparation of, or audited, the financial
statements, supporting schedules or other financial data filed with the Commission as a part of the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k) </B><B><I>Company</I></B><B><I>&#146;</I></B><B><I>s Accounting
System</I></B><B>.</B> The Company and each of its subsidiaries make and keep books and records that are accurate in all material respects and maintain a system of internal accounting controls sufficient to provide reasonable assurance that:
(i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorization; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
accountability for assets; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any differences and (v)&nbsp;the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Time of Sale Prospectus
and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l) </B><B><I>Disclosure Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial Reporting</I></B><B>.</B>
The Company has established and maintains disclosure controls and procedures (as defined in <FONT STYLE="white-space:nowrap">Rules&nbsp;13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15</FONT> under the Exchange Act), which (i)&nbsp;are
designed to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to the Company&#146;s principal executive officer and its principal financial officer by others within those entities,
particularly during the periods in which the periodic reports required under the Exchange Act are being prepared; (ii)&nbsp;have been evaluated by management of the Company for effectiveness as of the end of the Company&#146;s most recent fiscal
quarter; and (iii)&nbsp;are effective in all material respects to perform the functions for which they were established. Since the end of the Company&#146;s most recent audited fiscal year, there have been no significant deficiencies or material
weakness in the Company&#146;s internal control over financial reporting (whether or not remediated) and no change in the Company&#146;s internal control over financial reporting that has materially affected, or is reasonably likely to materially
affect, the Company&#146;s internal control over financial reporting. The Company is not aware of any change in its internal control over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the Company&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m) </B><B><I>Incorporation and
Good Standing of the Company</I></B><B>.</B> The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation and has the corporate power and authority to own,
lease and operate its properties and to conduct its business as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus and to enter into and perform its obligations under this Agreement. The Company is duly qualified
as a foreign corporation to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, in each case except where the
failure to be so qualified or in good standing would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(n) </B><B><I>Subsidiaries</I></B><B>.</B> Each &#147;significant subsidiary&#148; (as such term is defined in Rule <FONT
STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X)</FONT> of the Company and each of the Transferred Subsidiaries (each a &#147;Subsidiary&#148; and collectively, the &#147;Subsidiaries&#148;) has been duly
incorporated or organized, as the case may be, and is validly existing as a corporation, partnership or limited liability company, as applicable, in good standing under the laws of the jurisdiction of its incorporation or organization and has the
power and authority (corporate or other) to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus. Each of the Company&#146;s Subsidiaries is duly
qualified as a foreign corporation, partnership or limited liability company, as applicable, to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of
property or the conduct of business, in each case except where the failure to be so qualified or in good standing would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. All of the issued and
outstanding capital stock or other equity or ownership interests of each of the Company&#146;s subsidiaries have been duly authorized and validly issued, are fully paid and nonassessable and are owned by the Company, directly or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse claim other than in favor of the senior lender to the Company&#146;s corporate
structure. None of the outstanding capital stock or equity interest in any subsidiary was issued in violation of preemptive or similar rights of any security holder of such subsidiary. The Company does not own or control, directly or indirectly, any
corporation, association or other entity other than (a)&nbsp;the subsidiaries listed in Exhibit&nbsp;21 to the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023 and
(b)&nbsp;such other subsidiaries which, considered in the aggregate as a single entity, would not constitute a &#147;significant subsidiary&#148; as defined in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT
STYLE="white-space:nowrap">S-X.</FONT> <B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(o) </B><B><I>Capitalization and Other Capital Stock Matters</I></B><B>.</B> The
authorized, issued and outstanding capital stock of the Company is as set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus under the caption &#147;Capitalization&#148; (other than for subsequent issuances, if any,
pursuant to employee benefit plans, or upon the exercise of outstanding options or warrants, in each case as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus). The Shares (including the Offered Shares) conform
in all material respects to the description thereof contained in the Time of Sale Prospectus. All of the issued and outstanding Shares have been duly authorized and validly issued, are fully paid and nonassessable and have been issued in compliance
with all federal and state securities laws. None of the outstanding Shares was issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company. There are no
authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or any of its
subsidiaries other than those described in the Registration Statement, the Time of Sale Prospectus and the Prospectus. The descriptions of the Company&#146;s stock option, stock bonus and other stock plans or arrangements, and the options or other
rights granted thereunder, set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus accurately and fairly presents in all material respects the information required to be shown with respect to such plans, arrangements,
options and rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(p) </B><B><I>Stock Exchange Listing</I></B><B>.</B> The Shares are registered pursuant to Section&nbsp;12(b) or
12(g) of the Exchange Act and are listed on the Nasdaq Global Select Market (&#147;<B>Nasdaq</B>&#148;), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Shares under the Exchange
Act or delisting the Shares from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. To the Company&#146;s knowledge, it is in compliance with all applicable
listing requirements of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(q) </B><B><I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT> of Existing Instruments; No
Further Authorizations or Approvals Required</I></B><B>.</B> Neither the Company nor any of its subsidiaries is in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws,</FONT> partnership agreement or operating agreement or similar
organizational documents, as applicable, or is in default (or, with the giving of notice or lapse of time, would be in default) (&#147;<B>Default</B>&#148;) under any indenture, loan, credit agreement, note, lease, license agreement, contract,
franchise or other instrument (including, without limitation, any pledge agreement, security agreement, mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company or any of its
subsidiaries is a party or by which it or any of them may be bound, or to which any of their respective properties or assets are subject (each, an &#147;<B>Existing Instrument</B>&#148;), except for such Defaults as would not reasonably be expected,
individually or in the aggregate, to result in a Material Adverse<B> </B>Change. The Company&#146;s execution, delivery and performance of this Agreement, consummation of the transactions contemplated hereby and by the Registration Statement, the
Time of Sale Prospectus and the Prospectus and the issuance and sale of the Offered Shares (including the use of proceeds from the sale of the Offered Shares as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus
under the caption &#147;Use of Proceeds&#148;) (i)&nbsp;have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws,</FONT> partnership
agreement or operating agreement or similar organizational documents, as applicable, of the Company or any subsidiary (ii)&nbsp;will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance
upon any property or assets of the Company or any of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument and (iii)&nbsp;will not result in any violation of any law, administrative regulation or
administrative or court decree applicable to the Company or any of its subsidiaries, except in the case of clauses (ii)&nbsp;and (iii) for such conflicts, breaches, Defaults, liens, charges, encumbrances or violations that would not reasonably be
expected, individually or in the aggregate, to result in a Material Adverse Change. No consent, approval, authorization or other order of, or registration or filing with, any court or other governmental or regulatory authority or agency, is required
for the Company&#146;s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby and by the Registration Statement, the Time of Sale Prospectus and the Prospectus, except such as have been
obtained or made by the Company and are in full force and effect under the Securities Act and such as may be required under applicable state securities or blue sky laws or FINRA Rules. As used herein, a &#147;<B>Debt Repayment Triggering
Event</B>&#148; means any event or condition which gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#146;s behalf) the right to
require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(r) </B><B><I>Compliance with Laws</I></B><B><I>.</I></B> The Company and its subsidiaries have been and are in compliance with all
applicable laws, rules and regulations, except where failure to be so in compliance would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(s) </B><B><I>No Material Actions or Proceedings</I></B><B>.</B> Except as otherwise disclosed in the Registration Statement, the Time of
Sale Prospectus and the Prospectus, (i)&nbsp;there is no action, suit, proceeding, inquiry or investigation (&#147;Proceeding&#148;) brought by or before any arbitrator, court, governmental body, regulatory body, administrative agency, or other
authority, body or agency having jurisdiction over the Company or any of its subsidiaries (each, a &#147;Governmental Entity&#148;) now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its
subsidiaries, which would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change or materially and adversely affect the consummation of the transactions contemplated by this Agreement or the performance by
the Company of its obligations hereunder; and (ii)&nbsp;the aggregate of all pending legal or governmental proceedings to which the Company or any such subsidiary, is a party or of which any of their respective properties or assets is the subject,
including ordinary routine litigation incidental to the business, if determined adversely to the Company, would not reasonably be expected to result in a Material Adverse Change. No material labor dispute with the employees of the Company or any of
its subsidiaries, or, to the Company&#146;s knowledge, with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened or imminent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(t) </B><B><I>Intellectual Property Rights</I></B><B>.</B><B></B>&nbsp;The Company and its subsidiaries own or possess adequate rights to
use all patents, patent applications, trademarks, trade names, service names, copyrights, trade secrets and other intellectual property described in the Registration Statement, the Time of Sale Prospectus or the Prospectus and as being owned or
licensed by any of them and that are necessary for the conduct of their respective businesses as currently conducted or as currently proposed to be conducted as described in the Registration Statement, the Time of Sale Prospectus or the Prospectus
(collectively, the &#147;<B>Intellectual Property</B>&#148;), and the Company is unaware of any claim to the contrary or any challenge by any other person to the rights of the Company or any of its subsidiaries with respect to the Intellectual
Property that if determined adversely to the Company or any of its subsidiaries, would result in, individually or in the aggregate, a Material Adverse Change; to the Company&#146;s knowledge, neither the Company nor any of its subsidiaries has
infringed or is infringing the intellectual property of a third party, and neither the Company nor any subsidiary has received notice of a claim by a third party to the contrary, except for any such notice that would not reasonably be expected to
result in a Material Adverse Change. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(u) </B><B><I>All Necessary Permits, etc</I></B><B>.</B> The Company and its subsidiaries
possess such valid and current certificates, authorizations, licenses, approvals, consents, registrations, certificates of need, orders, accreditations, waivers, certifications, provider or supplier numbers, or permits required by state, federal or
foreign regulatory agencies or bodies to conduct their respective businesses as currently conducted and as described in the Registration Statement, the Time of Sale Prospectus or the Prospectus (&#147;<B>Permits</B>&#148;) except where any failures
to possess, singularly or in the aggregate, would not result in a Material Adverse Change. Except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change, neither the Company nor any of its
subsidiaries is in violation of, or in default under, any of the Permits or has received any notice of Proceedings relating to the revocation or modification of, or <FONT STYLE="white-space:nowrap">non-compliance</FONT> with, any such Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(v) </B><B><I>Title to Properties</I></B><B>.</B> The Company and its subsidiaries have good and marketable title to all of the real and
personal property and other assets reflected as owned in the financial statements referred to in Section&nbsp;1A(j) above (or elsewhere in the Registration Statement, the Time of Sale Prospectus or the Prospectus), in each case free and clear of any
security interests, mortgages, liens, encumbrances, equities, adverse claims and other defects except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or
(ii)&nbsp;would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. The real property, improvements, equipment and personal property held under lease by the Company or any of its subsidiaries are
held under valid and enforceable leases, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of such real property, improvements, equipment or personal property by the Company or such
subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(w) </B><B><I>Tax Law Compliance</I></B><B>.</B> The Company and its subsidiaries have filed all necessary federal, state
and foreign income and franchise tax returns or have properly requested extensions thereof and have paid all taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of
them except as may be being contested in good faith and by appropriate proceedings in each case except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change. The Company has made adequate
charges, accruals and reserves in accordance with GAAP in the applicable financial statements referred to in Section&nbsp;1A(j) above in respect of all federal, state and foreign income and franchise taxes for all periods as to which the tax
liability of the Company or any of its subsidiaries has not been finally determined. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(x) </B><B><I>Insurance</I></B><B>.</B> Each of
the Company and its subsidiaries are insured with policies in such amounts and with such deductibles and covering such risks as are generally deemed adequate and customary for their businesses. The Company has no reason to believe that it or any of
its subsidiaries will not be able (i)&nbsp;to renew its existing insurance coverage as and when such policies expire or (ii)&nbsp;to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as
now conducted and at a cost that would not reasonably be expected to result in a Material Adverse Change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(y) </B><B><I>Compliance
with Environmental Laws</I></B><B>.</B> Except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change: (i)&nbsp;neither the Company nor any of its subsidiaries is in violation of any federal,
state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to
pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the
release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively, &#147;<B>Hazardous Materials</B>&#148;) or to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
handling of Hazardous Materials (collectively, &#147;<B>Environmental Laws</B>&#148;); (ii) the Company and its subsidiaries have all permits, authorizations and approvals required under any
applicable Environmental Laws and are each in compliance with their requirements; (iii)&nbsp;there are no pending or threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance
or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries; and (iv)&nbsp;there are no events or circumstances that might reasonably be expected to form the basis of an order for <FONT
STYLE="white-space:nowrap">clean-up</FONT> or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any
Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(z) </B><B><I>ERISA Compliance</I></B><B>.</B> Except as would not reasonably be expected to result in a Material
Adverse Change, the Company and its subsidiaries and any &#147;employee benefit plan&#148; (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively,
&#147;<B>ERISA</B>&#148;)) established or maintained by the Company, its subsidiaries or their &#147;ERISA Affiliates&#148; (as defined below) are in compliance in all material respects with ERISA. &#147;<B>ERISA Affiliate</B>&#148; means, with
respect to the Company or any of its subsidiaries, any member of any group of organizations described in Sections&nbsp;414(b), (c), (m) or (o)&nbsp;of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations
thereunder (the &#147;<B>Code</B>&#148;) of which the Company or such subsidiary is a member. No &#147;reportable event&#148; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#147;employee benefit
plan&#148; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates. No &#147;employee benefit plan&#148; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates, if such
&#147;employee benefit plan&#148; were terminated, would have any &#147;amount of unfunded benefit liabilities&#148; (as defined under ERISA). Neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects
to incur any liability under (i)&nbsp;Title&nbsp;IV of ERISA with respect to termination of, or withdrawal from, any &#147;employee benefit plan&#148; or (ii)&nbsp;Sections&nbsp;412, 4971, 4975 or 4980B of the Code. Each employee benefit plan
established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section&nbsp;401(a) of the Code is so qualified and nothing has occurred, whether by action or failure to act, which
would cause the loss of such qualification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(aa) </B><B><I>Company Not an </I></B><B><I>&#147;</I></B><B><I>Investment
Company.</I></B><B><I>&#148;</I></B> The Company is not, and will not be, either after receipt of payment for the Offered Shares or after the application of the proceeds therefrom as described under &#147;Use of Proceeds&#148; in the Registration
Statement, the Time of Sale Prospectus or the Prospectus, required to register as an &#147;investment company&#148; under the Investment Company Act of 1940, as amended (the &#147;<B>Investment Company Act</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(bb) </B><B><I>No Price Stabilization or Manipulation</I></B><B><I>; Compliance with Regulation M</I></B><B>.</B> Neither the Company nor
any of its subsidiaries has taken, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in stabilization or manipulation of the price of the Shares or of any &#147;reference security&#148; (as
defined in Rule 100 of Regulation M under the Exchange Act (&#147;<B>Regulation</B><B></B><B>&nbsp;M</B>&#148;)) with respect to the Shares, whether to facilitate the sale or resale of the Offered Shares or otherwise, and has taken no action which
would directly or indirectly violate Regulation M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(cc) </B><B><I>Related-Party Transactions</I></B><B>.</B> There are no business
relationships or related-party transactions involving the Company or any of its subsidiaries or any other person required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus that have not been described as
required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(dd) </B><B><I>FINRA Matters</I></B><B>.</B> All of the information provided to the
Underwriters or to counsel for the Underwriters by the Company, its counsel, its officers and directors and, to the Company&#146;s knowledge, by the holders of any securities (debt or equity) or options to acquire any securities of the Company in
connection with the offering of the Offered Shares is true, complete, correct and compliant in all material respects with FINRA Rules, and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules is true,
complete and correct in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>ee</B><B>) </B><B><I>Parties to <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreements</I></B><B>.</B> The Company has furnished to the Underwriters a letter agreement in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;A</U> (the &#147;<B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement</B>&#148;) from
each of the persons or entities listed on <U>Exhibit</U><U></U><U>&nbsp;B</U>. Such <U>Exhibit</U><U></U><U>&nbsp;B</U> lists under an appropriate caption the directors and officers of the Company. If any additional persons shall become directors or
officers of the Company prior to the end of the Company <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period (as defined below), the Company shall cause each such person, prior to or contemporaneously with their appointment or election as a
director or officer of the Company, to execute and deliver to the Representatives a <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ff) </B><B><I>Statistical and Market-Related Data</I></B><B>.</B> All statistical, demographic and
<FONT STYLE="white-space:nowrap">market-related</FONT> data included in the Registration Statement, the Time of Sale Prospectus or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate. To the
extent required, the Company has obtained the written consent to the use of such data from such sources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(gg) </B><B><I>No Unlawful
Contributions or Other Payments</I></B><B>.</B> Neither the Company nor any of its subsidiaries nor, to the best of the Company&#146;s knowledge, any employee or agent of the Company or any subsidiary, has made any contribution or other payment to
any official of, or candidate for, any federal, state or foreign office in violation of any law or of the character required to be disclosed in the Registration Statement, the Time of Sale Prospectus or the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>hh</B><B>) </B><B><I>Anti-Corruption and Anti-Bribery Laws</I></B><B>.</B> Neither the Company nor any of its subsidiaries nor any
director, officer, or employee of the Company or any of its subsidiaries acting on behalf of the Company or any of its subsidiaries, nor to the knowledge of the Company, any agent, affiliate or other person acting on behalf of the Company or any of
its subsidiaries has, in the course of its actions for, or on behalf of, the Company or any of its subsidiaries (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political
activity; (ii)&nbsp;made or taken any act in furtherance of an offer, promise, or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or
controlled entity or public international organization, or any political party, party official, or candidate for political office; (iii)&nbsp;violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended
(the &#147;<B>FCPA</B>&#148;), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv)&nbsp;made, offered, authorized, requested, or taken an act in furtherance of any unlawful bribe, rebate, payoff, influence
payment, kickback or other unlawful payment or benefit. The Company and its subsidiaries and, to the knowledge of the Company, the Company&#146;s affiliates have conducted their respective businesses in compliance with the FCPA and have instituted
and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B><B><I>Money Laundering Laws</I></B><B>.</B> The operations of the Company and its subsidiaries are, and have been conducted at all
times, in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and
regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<B>Money Laundering Laws</B>&#148;) and no action, suit or proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(jj) </B><B><I>Sanctions</I></B><B>.</B> Neither the Company nor any of its subsidiaries,
directors, officers, or employees, nor, to the knowledge of the Company, after due inquiry, any agent, affiliate, or other person acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;<B>OFAC</B>&#148;) or the U.S. Department of State, the United Nations Security Council, the European Union, His Majesty&#146;s Treasury of the United
Kingdom, or other relevant sanctions authority (collectively, &#147;<B>Sanctions</B>&#148;); nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions,
including, without limitation, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk
People&#146;s Republic, and the <FONT STYLE="white-space:nowrap">non-government</FONT> controlled areas of the Zaporizhzhia and Kherson regions of Ukraine (each a &#147;<B>Sanctioned Country</B>&#148;); and the Company will not directly or
indirectly use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other person or entity, for the purpose of financing the activities of or business with
any person, or in any country or territory, that at the time of such financing, is the subject or the target of Sanctions or in any other manner that will result in a violation by any person (including any person participating in the transaction
whether as underwriter, advisor, investor or otherwise) of applicable Sanctions. For the past ten years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person
that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>kk</B><B>) </B><B><I>Brokers</I></B><B>.</B> Except pursuant to this Agreement, there is no broker, finder or other party that is
entitled to receive from the Company any brokerage or finder&#146;s fee or other fee or commission as a result of any transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ll) </B><B><I>Forward-Looking Statements.</I></B> Each financial or operational projection or other &#147;forward-looking statement&#148;
(as defined by Section&nbsp;27A of the Securities Act or Section&nbsp;21E of the Exchange Act) contained in the Registration Statement, the Time of Sale Prospectus or the Prospectus (i)&nbsp;was so included by the Company in good faith and with
reasonable basis after due consideration by the Company of the underlying assumptions, estimates and other applicable facts and circumstances and (ii)&nbsp;is accompanied by meaningful cautionary statements identifying those factors that could cause
actual results to differ materially from those in such <FONT STYLE="white-space:nowrap">forward-looking</FONT> statement. No such statement was made with the knowledge of an executive officer or director of the Company that it was false or
misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(mm) </B><B><I>Medicare and Medicaid Programs.</I></B> Each of the Company and its subsidiaries has the requisite provider
number or other authorization to bill the Medicare program and the respective Medicaid program in the state or states in which such entity operates; neither the Company nor any of its subsidiaries is subject to any pending or, to the Company&#146;s
knowledge, threatened or contemplated action which would reasonably be expected to result either in a revocation of any provider number or authorization or in the Company&#146;s or any subsidiary&#146;s exclusion from the Medicare or any state
Medicaid programs. There are no material suspensions, offsets or recoupments of any such program or third-party payor payments being sought, requested or claimed, or to the Company&#146;s knowledge, threatened against the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(nn) </B><B><I>Compliance with Data Privacy Laws. </I></B>Except where <FONT STYLE="white-space:nowrap">non-compliance</FONT> would not,
individually or in the aggregate, reasonably be expected to result in a Material Adverse Change, the Company and its subsidiaries are and have been in compliance with all applicable laws or statutes (collectively, the &#147;<B>Privacy
Laws</B>&#148;) and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations, each relating to the privacy and security of IT Systems and Personal
Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification (collectively, &#147;<B>Data Protection Requirements</B>&#148;). Neither the Company nor any subsidiary: (i)&nbsp;has
received notice of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any actual or potential liability under or relating to, or actual or potential violation of, any of the Data Protection Requirements, except where
<FONT STYLE="white-space:nowrap">non-compliance</FONT> would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change and to the Company&#146;s knowledge no such notices are threatened; (ii)&nbsp;is
currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Data Protection Requirement that would, individually or in the aggregate reasonably be expected to have a Material
Adverse Change related to any <FONT STYLE="white-space:nowrap">non-compliance;</FONT> or (iii)&nbsp;is a party to any order, decree, or agreement that imposes any material obligation or liability by any Governmental Entity with respect to compliance
with any Data Protection Requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(oo) </B><B><I>Healthcare Laws</I></B>. Except where the failure to comply would not be
expected, singly or in the aggregate, to result in a Material Adverse Change, each of the Company and its subsidiaries is and has been in compliance with all applicable Health Care Laws, and has not engaged in activities which could provide, as
applicable, cause for false claims liability, civil penalties, or mandatory or permissive exclusion from Medicare, Medicaid, or any other state health care program or federal health care program. The term &#147;Healthcare Laws&#148; shall include
any applicable federal, state, local or foreign statute, law, rule, guidance, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order,
consent, decree or judgment, relating to healthcare services, reimbursement, fraud and abuse, conditions for participation, or the privacy, security, use and disclosure of individually identifiable health information, including<U>:</U> Title XVIII
of the Social Security Act, (the Medicare statute), Title XIX of the Social Security Act, (the Medicaid statute); the Ethics in Patient Referrals Act, (the Stark Law), 42 U.S.C. &#167; 1395nn; the Federal Health Care Program Anti-Kickback Statute,
42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(b);</FONT> the False Claims Act, 31 U.S.C. &#167;&#167; 3729-3733; the Program Fraud Civil Remedies Act, 31 U.S.C. &#167;&#167; 3801-3812; the Anti-Kickback Act of 1986, 41 U.S.C.
&#167;&#167; <FONT STYLE="white-space:nowrap">51-58;</FONT> the Civil Monetary Penalties Law, 42 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">1320a-7a</FONT> and <FONT STYLE="white-space:nowrap">1320a-7b;</FONT> the Exclusion Laws, 42 U.S.C.
&#167; <FONT STYLE="white-space:nowrap">1320a-7;</FONT> TRICARE, 10 U.S.C. &#167; 1071 et seq.; HIPAA, as amended by the HITECH Act; any criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. Sections 286, 287,
1035, 1347 and 1349; and all applicable foreign, federal, state, and local licensing, certificate of need, privacy, corporate practice of medicine, fee splitting, false claims, anti-kickback or self-referral, laws requiring disclosure of financial
interest, regulatory and reimbursement laws; each as amended and together with regulations promulgated pursuant to such laws. None of the Company or its subsidiaries has received any correspondence, communication or notice from any Governmental
Entity alleging or asserting noncompliance with any Health Care Laws applicable to the Company or its subsidiaries, except where the failure to comply would not be expected, individually or in the aggregate, to result in a Material Adverse Change.
None of the Company or its subsidiaries is a party to, or has any ongoing reporting obligations pursuant to, any corporate integrity agreements, deferred or <FONT STYLE="white-space:nowrap">non-prosecution</FONT> agreements, monitoring agreements,
consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Governmental Entity. None of the Company, its subsidiaries nor, to the knowledge of the Company, any of their respective officers, directors,
employees or independent contractors, (i)&nbsp;is or has been excluded, suspended or debarred from participation in any federal health care program or (ii)&nbsp;is subject to a Proceeding that could reasonably be expected to result in debarment,
suspension, or exclusion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(pp) </B><B><I>Dividend Restrictions</I></B><B>.</B> No subsidiary of the Company is prohibited or
restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution with respect to such subsidiary&#146;s equity securities or from repaying to the Company or any other subsidiary of the Company any
amounts that may from time to time become due under any loans or advances to such subsidiary from the Company or from transferring any property or assets to the Company or to any other subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(qq) </B><B><I>Sarbanes-Oxley Act.</I></B> There is, and has been, no failure on the part of the Company or any of the Company&#146;s
directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith, including Section&nbsp;402 related to loans
and Sections 302 and 906 related to certifications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(rr) </B><B><I>Cybersecurity</I></B>. The Company and its subsidiaries&#146; information
technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#147;<B>IT Systems</B>&#148;) are adequate for, and operate and perform in all material respects as required in
connection with the operation of the business of the Company and its subsidiaries as currently conducted, and except as would not reasonably be expected to result in a Material Adverse Change, are free and clear of all material bugs, errors,
defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to
maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including &#147;Personal Data,&#148; used in connection with their businesses.
&#147;<B>Personal Data</B>&#148; means (i)&nbsp;a natural person&#146;s name, street address, telephone number, <FONT STYLE="white-space:nowrap">e-mail</FONT> address, photograph, social security number or tax identification number, driver&#146;s
license number, passport number, credit card number, bank information, or customer or account number; and (ii)&nbsp;any information which would qualify as &#147;personal information,&#148; &#147;personal data,&#148; &#147;protected health
information,&#148; or the equivalent term under Privacy Laws. There have been no material breaches, violations, outages or unauthorized uses of or accesses to the Company and its subsidiaries IT Systems and data, except for those that have been
remedied without material cost or liability or the duty to notify any other person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ss) </B><B><I>No Outstanding Loans or Other
Extensions of Credit</I></B>. The Company does not have any outstanding extension of credit, in the form of a personal loan, to or for any director or executive officer (or equivalent thereof) of the Company except for such extensions of credit as
are expressly permitted by Section&nbsp;13(k) of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(tt) </B><B><I>Acquisition Agreement. </I></B>(i)&nbsp;The Company
has all requisite corporate power and authority to consummate the Acquisition and to enter into and perform its obligations under the Acquisition Agreement, and (ii)&nbsp;the Acquisition Agreement has been duly and validly authorized, executed and
delivered by the Company and, assuming due authorization, execution and delivery by the other parties thereto, constitutes a valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except as
enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable principles relating to enforceability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(uu) </B><B><I>Acquisition Agreement Representations.</I></B> Nothing has come to the attention of the Company that would cause it to
believe that the Acquisition will not be consummated substantially in accordance with the terms of the Acquisition Agreement or the description of the Acquisition Agreement included or incorporated by reference in the Time of Sale Prospectus and the
Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate signed by any officer of the Company or any of its subsidiaries and delivered to any Underwriter, or to
counsel for the Underwriters, in connection with the offering, or the purchase and sale, of the Offered Shares shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has a reasonable basis for making each of the representations set forth in this Section&nbsp;1A. The Company acknowledges that the
Underwriters and, for purposes of the opinions to be delivered pursuant to Section&nbsp;6 hereof, counsel to the Company and counsel to the Underwriters, will rely upon the accuracy and truthfulness of the foregoing representations and hereby
consents to such reliance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>B. [Reserved]. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2. </B><B>Purchase, Sale and Delivery of the Offered Shares</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><I>The Firm Shares</I></B><B>.</B> Upon the terms herein set forth, the Company agrees to issue and sell to the several
Underwriters an aggregate of 1,500,000 Firm Shares. On the basis of the representations, warranties and agreements herein contained, and upon the terms but subject to the conditions herein set forth, the Underwriters agree, severally and not
jointly, to purchase from the Company the respective number of Firm Shares set forth opposite their names on <U>Schedule</U><U> A</U>. The Firm Shares are to be offered to the public initially at $108.00 per share (the &#147;<B>Public Offering
Price</B>&#148;). The purchase price per Firm Share to be paid by the several Underwriters to the Company shall be $102.06 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><I>The First Closing Date</I></B><B>.</B> Delivery of the Firm Shares to be purchased by the Underwriters and payment therefor
shall be made at the offices of Latham&nbsp;&amp; Watkins LLP (or such other place as may be agreed to by the Company and the Representatives) at 9:00 a.m. New York City time, on June&nbsp;28, 2024, or such other time as agreed upon by the Company
and the Representatives (the time and date of such closing are called the &#147;<B>First Closing Date</B>&#148;). The Company hereby acknowledges that circumstances under which the Representatives may provide notice to postpone the First Closing
Date as originally scheduled include, but are not limited to, any determination by the Company or the Representatives to recirculate to the public copies of an amended or supplemented Prospectus or a delay as contemplated by the provisions of
Section&nbsp;11. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B><I>The Optional Shares; Option Closing Date</I></B><B>.</B> In addition, on the basis of the
representations, warranties and agreements herein contained, and upon the terms but subject to the conditions herein set forth, the Company hereby grants an option to the several Underwriters to purchase, severally and not jointly, up to an
aggregate of 225,000 Optional Shares at the purchase price per share to be paid by the Underwriters for the Firm Shares, less an amount per share equal to any dividend or distribution declared by the Company and payable on the Firm Shares but not
payable on Optional Shares. The option granted hereunder may be exercised at any time and from time to time in whole or in part upon notice by the Representatives to the Company, which notice may be given at any time within 30&nbsp;days from the
date of this Agreement. Such notice shall set forth (i)&nbsp;the aggregate number of Optional Shares as to which the Underwriters are exercising the option and (ii)&nbsp;the time, date and place at which the Optional Shares will be delivered (which
time and date may be simultaneous with, but not earlier than, the First Closing Date; and in the event that such time and date are simultaneous with the First Closing Date, the term &#147;<B>First Closing Date</B>&#148; shall refer to the time and
date of delivery of the Firm Shares and such Optional Shares). Any such time and date of delivery, if subsequent to the First Closing Date, is called an &#147;<B>Option Closing Date</B>,&#148; and shall be determined by the Representatives and shall
not be earlier than two or later than five full business days after delivery of such notice of exercise. If any Optional Shares are to be purchased, each Underwriter agrees, severally and not jointly, to purchase the number of Optional Shares
(subject to such adjustments to eliminate fractional shares as the Representatives may determine) that bears the same proportion to the total number of Optional Shares to be purchased as the number of Firm Shares set forth on <U>Schedule A</U>
opposite the name of such Underwriter bears to the total number of Firm Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B>The Representatives may cancel the option at
any time prior to its expiration by giving written notice of such cancellation to the Company.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) </B><B><I>Public Offering
of the Offered Shares</I></B><B>.</B> The Representatives hereby advise the Company that the Underwriters intend to offer for sale to the public, initially on the terms set forth in the Registration Statement, the Time of Sale Prospectus and the
Prospectus, their respective portions of the Offered Shares as soon after this Agreement has been executed as the Representatives, in their sole judgment, have determined is advisable and practicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) </B><B><I>Payment for the Offered Shares</I></B><B>.</B> (i)&nbsp;Payment for the
Firm Shares to be sold by the Company shall be made at the First Closing Date by wire transfer of immediately available funds to the order of the Company. Payment for the Optional Shares, if any, to be sold by the Company shall be made at the First
Closing Date, or the applicable Option Closing Date, as the case may be, by wire transfer of immediately available funds to the order of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) It is understood that the Representatives have been authorized, for their own account and the accounts of the several
Underwriters, to accept delivery of and receipt for, and make payment of the purchase price for, the Firm Shares and any Optional Shares the Underwriters have agreed to purchase. Each of BofA and Jefferies, individually and not as the
Representatives of the Underwriters, may (but shall not be obligated to) make payment for any Offered Shares to be purchased by any Underwriter whose funds shall not have been received by the Representatives by the First Closing Date or the
applicable Option Closing Date, as the case may be, for the account of such Underwriter, but any such payment shall not relieve such Underwriter from any of its obligations under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) [Reserved]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) </B><B><I>Delivery of the Offered Shares</I></B><B>.</B> The Company shall deliver, or cause to be delivered to the Representatives,
through the book entry facilities of the DTC for the accounts of the several Underwriters the Firm Shares to be sold by them at the First Closing Date, against release of a wire transfer of immediately available funds for the amount of the purchase
price therefor. The Company shall also deliver, or cause to be delivered to the Representatives, through the book entry facilities of the DTC, for the accounts of the several Underwriters, the Optional Shares the Underwriters have agreed to purchase
from them at the First Closing Date or the applicable Option Closing Date, as the case may be, against the release of a wire transfer of immediately available funds for the amount of the purchase price therefor. The Offered Shares shall be
registered in such names and denominations as the Representatives shall have requested at least two full business days prior to the First Closing Date (or the applicable Option Closing Date, as the case may be) and shall be made available for
inspection on the business day preceding the First Closing Date (or the applicable Option Closing Date, as the case may be) at a location in New York City as the Representatives may designate. Time shall be of the essence, and delivery at the time
and place specified in this Agreement is a further condition to the obligations of the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3. Additional
Covenants of the Company.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A.</B> <B><I>Covenants</I></B><B><I> of the Company</I></B>. The Company further covenants and agrees
with each Underwriter as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><I>Commission Filing Fees</I></B>. The Company agrees to pay the required Commission
filing fees relating to the Offered Shares within the time required by Rule 456(b)(1) under the Securities Act without regard to the proviso therein and otherwise in accordance with the Rules 456(b) and 457(r) under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><I>Delivery of Registration Statement, Time of Sale Prospectus and Prospectus</I></B><B><I>.</I></B><I> </I>The Company shall
furnish to the Representatives in New York City, without charge, prior to 10:00 a.m. New York City time on the business day next succeeding the date of this Agreement and during the period when a prospectus relating to the Offered Shares is required
by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) in connection with sales of the Offered Shares, as many copies of the Time of Sale Prospectus, the Prospectus
and any supplements and amendments thereto or to the Registration Statement as the Representatives may reasonably request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B><I>Representatives&#146; Review of Proposed Amendments and
Supplements.</I></B><I> </I>During the period when a prospectus relating to the Offered Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule),
the Company (i)&nbsp;will furnish to the Representatives for review, a reasonable period of time prior to the proposed time of filing of any proposed amendment or supplement to the Registration Statement, a copy of each such amendment or supplement
and (ii)&nbsp;will not amend or supplement the Registration Statement (including any amendment or supplement through incorporation of any report filed under the Exchange Act) without the Representatives&#146; prior written consent. Prior to amending
or supplementing any preliminary prospectus, the Time of Sale Prospectus or the Prospectus (including any amendment or supplement through incorporation of any report filed under the Exchange Act), the Company shall furnish to the Representatives for
review, a reasonable amount of time prior to the time of filing or use of the proposed amendment or supplement, a copy of each such proposed amendment or supplement. The Company shall not file or use any such proposed amendment or supplement without
the Representatives&#146; prior written consent. The Company shall file with the Commission within the applicable period specified in Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B><I>Free Writing Prospectuses</I></B><B><I>.</I></B><I> </I>The Company shall furnish to the Representatives for review, a
reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each proposed free writing prospectus or any amendment or supplement thereto prepared by or on behalf of, used by, or referred to by the Company, and the
Company shall not file, use or refer to any proposed free writing prospectus or any amendment or supplement thereto without the Representatives&#146; prior written consent. The Company shall furnish to each Underwriter, without charge, as many
copies of any free writing prospectus prepared by or on behalf of, used by or referred to by the Company as such Underwriter may reasonably request. If at any time when a prospectus is required by the Securities Act to be delivered (whether
physically or through compliance with Rule 172 under the Securities Act or any similar rule) in connection with sales of the Offered Shares (but in any event if at any time through and including the First Closing Date) there occurred or occurs an
event or development as a result of which any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company conflicted or would conflict with the information contained in the Registration Statement or included or would
include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such time, not misleading, the Company shall promptly
amend or supplement such free writing prospectus to eliminate or correct such conflict or so that the statements in such free writing prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such time, not misleading, as the case may be; <I>provided, however</I>, that prior to amending or supplementing any such free writing
prospectus, the Company shall furnish to the Representatives for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of such proposed amended or supplemented free writing prospectus, and the Company shall
not file, use or refer to any such amended or supplemented free writing prospectus without the Representatives&#146; prior written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) </B><B><I>Filing of Underwriter Free Writing Prospectuses.</I></B><I> </I>The Company shall not take any action that would result in an
Underwriter or the Company being required to file with the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that such Underwriter otherwise would not have been
required to file thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) </B><B><I>Amendments and Supplements to Time of Sale Prospectus</I></B><B><I>.</I></B><I> </I>If the
Time of Sale Prospectus is being used to solicit offers to buy the Offered Shares at a time when the Prospectus is not yet available to prospective purchasers, and any event shall occur or condition exist as a result of which it is necessary to
amend or supplement the Time of Sale Prospectus so that the Time of Sale Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the statements therein, in the light of the circumstances when delivered to a prospective purchaser, not misleading, or if any event shall occur or condition exist as a result of which the Time
of Sale Prospectus conflicts with the information contained in the Registration Statement, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, the
Company shall (subject to Section&nbsp;3A(c) and Section&nbsp;3A(d) hereof) promptly prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, either amendments or supplements to the Time
of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances when delivered to a prospective purchaser, not misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the information contained in the Registration Statement, or so that
the Time of Sale Prospectus, as amended or supplemented, will comply with applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) </B><B><I>Certain Notifications and
Required Actions</I></B><B>.</B> After the date of this Agreement and until such time as the Underwriters are no longer required to deliver a Prospectus in order to confirm sales of the Offered Shares, the Company shall promptly advise the
Representatives in writing of: (i)&nbsp;the receipt of any comments of, or requests for additional or supplemental information from, the Commission; (ii)&nbsp;the time and date of any filing of any post-effective amendment to the Registration
Statement or any amendment or supplement to any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus; (iii)&nbsp;the time and date that any post-effective amendment to the Registration Statement becomes
effective; and (iv)&nbsp;the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any amendment or supplement to any preliminary prospectus, the Time of
Sale Prospectus or the Prospectus or of any order preventing or suspending the use of any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus or the Prospectus, or of any proceedings to remove, suspend or terminate from
listing or quotation the Shares from any securities exchange upon which they are listed for trading or included or designated for quotation, or of the threatening or initiation of any proceedings for any of such purposes. If the Commission shall
enter any such stop order at any time, the Company will use its best efforts to obtain the lifting of such order at the earliest possible moment. Additionally, the Company agrees that it shall comply with all applicable provisions of
Rule&nbsp;424(b), Rule 433 and Rule 430B under the Securities Act and will use its reasonable efforts to confirm that any filings made by the Company under Rule 424(b) or Rule 433 were received in a timely manner by the Commission. If, after the
date of this Agreement and during any time when a prospectus is required by the Securities Act to be delivered (whether physically or through compliance with Rule&nbsp;172 under the Securities Act or any similar rule), the Company receives notice
pursuant to Rule 401(g)(2) under the Securities Act from the Commission or otherwise ceases to be eligible to use the automatic shelf registration form, the Company shall promptly advise the Representative in writing of such notice or ineligibility
and will (i)&nbsp;promptly file a new registration statement or post-effective amendment on the proper form relating to the Offered Shares, (ii)&nbsp;use its best efforts to cause such registration statement or post-effective amendment to be
declared effective by the Commission as soon as practicable and (iii)&nbsp;promptly notify the Representative in writing of such effectiveness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h) </B><B><I>Amendments and Supplements to the Prospectus and Other Securities Act Matters</I></B><B><I>.</I></B> If, during the period
when a prospectus related to the Offered Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule), any event shall occur or condition exist as a
result of which it is necessary to amend or supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of
the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a purchaser, not misleading, or if in the opinion of the Representatives or counsel for the
Underwriters it is otherwise necessary to amend or supplement the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus to comply with applicable law, the Company agrees (subject to Section&nbsp;3A(c) and Section&nbsp;3A(d)) hereof to promptly prepare, file with the Commission and furnish, at its own
expense, to the Underwriters and to any dealer upon request, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule) to a
purchaser, not misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law. Neither the Representatives&#146; consent to, nor delivery of, any such amendment or supplement shall constitute a waiver of any of the
Company&#146;s obligations under Section&nbsp;3A(c) or Section&nbsp;3A(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>) </B><B><I>Blue Sky
Compliance</I></B><B>.</B> The Company shall cooperate with the Representatives and counsel for the Underwriters to qualify or register the Offered Shares for sale under (or obtain exemptions from the application of) the state securities or blue sky
laws or Canadian provincial securities laws of those jurisdictions designated by the Representatives, shall comply with such laws and shall continue such qualifications, registrations and exemptions in effect so long as required for the distribution
of the Offered Shares. The Company shall not be required to qualify as a foreign corporation or to take any action that would subject it to general service of process in any such jurisdiction where it is not presently qualified or where it would be
subject to taxation as a foreign corporation. The Company will advise the Representatives promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Offered Shares for offering, sale or trading in any
jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain the withdrawal
thereof at the earliest possible moment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j) </B><B><I>Use of Proceeds</I></B><B>.</B> The Company shall apply the net proceeds from
the sale of the Offered Shares sold by it in the manner described under the caption &#147;Use of Proceeds&#148; in the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k) </B><B><I>Transfer Agent</I></B><B>.</B> The Company shall maintain, at its expense, a registrar and transfer agent for the Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l) </B><B><I>Earnings Statement</I></B><B>.</B> The Company will make generally available to its security holders and to the
Representatives as soon as practicable an earnings statement (which need not be audited) covering a period of at least twelve months beginning with the first fiscal quarter of the Company commencing after the date of this Agreement that will satisfy
the provisions of Section&nbsp;11(a) of the Securities Act and the rules and regulations of the Commission thereunder, which earnings statement shall be deemed to have been made generally available by the Company if the Company is in compliance with
its reporting obligations pursuant to the Exchange Act, if such compliance satisfies the conditions of Rule 158, and if such earnings statement is made available on EDGAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m) </B><B><I>Continued Compliance with Securities Laws</I></B><B>.</B> The Company will comply with the Securities Act and the Exchange
Act so as to permit the completion of the distribution of the Offered Shares as contemplated by this Agreement<B>, </B>the Registration Statement, the Time of Sale Prospectus and the Prospectus. Without limiting the generality of the foregoing, the
Company will, during the period when a prospectus relating to the Offered Shares is required by the Securities Act to be delivered (whether physically or through compliance with Rule 172 under the Securities Act or any similar rule), file on a
timely basis with the Commission and Nasdaq all reports and documents required to be filed under the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(n) </B><B><I>Listing</I></B><B>.</B> The Company will use its best efforts to list,
subject to notice of issuance, the Offered Shares on Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(o) </B><B><I>Company to Provide Copy of the Prospectus in Form That May
</I></B><B><I>be</I></B><B><I> Downloaded from the Internet</I></B>. If requested by the Representatives, the Company shall cause to be prepared and delivered, at its expense, within one business day from the effective date of this Agreement, to the
Representatives an &#147;electronic Prospectus&#148; to be used by the Underwriters in connection with the offering and sale of the Offered Shares. As used herein, the term &#147;electronic Prospectus&#148; means a form of Prospectus, and any
amendment or supplement thereto, that meets each of the following conditions: (i)&nbsp;it shall be encoded in an electronic format, reasonably satisfactory to the Representatives, that may be transmitted electronically by the Representatives and the
other Underwriters to offerees and purchasers of the Offered Shares; (ii)&nbsp;it shall disclose the same information as the paper Prospectus, except to the extent that graphic and image material cannot be disseminated electronically, in which case
such graphic and image material shall be replaced in the electronic Prospectus with a fair and accurate narrative description or tabular representation of such material, as appropriate; and (iii)&nbsp;it shall be in or convertible into a paper
format or an electronic format, reasonably satisfactory to the Representatives, that will allow investors to store and have continuously ready access to the Prospectus at any future time, without charge to investors (other than any fee charged for
subscription to the Internet as a whole and for <FONT STYLE="white-space:nowrap">on-line</FONT> time). The Company hereby confirms that it has included or will include in the Prospectus filed pursuant to EDGAR or otherwise with the Commission and in
the Registration Statement at the time it was declared effective an undertaking that, upon receipt of a request by an investor or his or her representative, the Company shall transmit or cause to be transmitted promptly, without charge, a paper copy
of the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(p) </B><B><I>Agreement Not to Offer or Sell Additional Shares</I></B><B>.</B> During the period commencing on and
including the date hereof and continuing through and including the 60th day following the date of the Prospectus (such period, as extended as described below, being referred to herein as the &#147;<B><FONT STYLE="white-space:nowrap">Lock-up</FONT>
Period</B>&#148;), the Company will not, without the prior written consent of (1)&nbsp;BofA and (2)&nbsp;Jefferies (which consent may be withheld in their sole discretion), directly or indirectly: (i)&nbsp;sell, offer to sell, contract to sell or
lend any Shares or Related Securities (as defined below); (ii) effect any short sale, or establish or increase any &#147;put equivalent position&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act) or
liquidate or decrease any &#147;call equivalent position&#148; (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;16a-1(b)</FONT> under the Exchange Act) of any Shares or Related Securities; (iii)&nbsp;pledge, hypothecate or grant any
security interest in any Shares or Related Securities; (iv)&nbsp;in any other way transfer or dispose of any Shares or Related Securities; (v)&nbsp;enter into any swap, hedge or similar arrangement or agreement that transfers, in whole or in part,
the economic risk of ownership of any Shares or Related Securities, regardless of whether any such transaction is to be settled in securities, in cash or otherwise; (vi)&nbsp;announce the offering of any Shares or Related Securities; (vii)&nbsp;file
any registration statement under the Securities Act in respect of any Shares or Related Securities (other than as contemplated by this Agreement with respect to the Offered Shares); or (viii)&nbsp;effect a reverse stock split, recapitalization,
share consolidation, reclassification or similar transaction affecting the outstanding Shares; or (ix)&nbsp;publicly announce the intention to do any of the foregoing; <I>provided, however</I>, that the Company may (A)&nbsp;effect the transactions
contemplated hereby, (B)&nbsp;issue Shares or options to purchase Shares, or issue Shares upon exercise of options, pursuant to any stock option, stock bonus or other stock plan or arrangement described in the Registration Statement, the Time of
Sale Prospectus and the Prospectus, but only if the holders (to the extent such holders are the Company&#146;s executive officers or directors) of such Shares or options agree in writing with the Underwriters not to sell, offer, dispose of or
otherwise transfer any such Shares or options during such <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period (subject to such exceptions as may be agreed to by the Representatives in the applicable <FONT STYLE="white-space:nowrap">Lock-up</FONT>
Agreement) without the prior written consent of (1)&nbsp;BofA and (2)&nbsp;Jefferies (which consent may be withheld in their sole discretion), (C) file a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> with respect to any
securities issued or issuable pursuant to any stock option, stock bonus or other stock plan or arrangement described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, (D)&nbsp;assist any stockholder of the Company in the
establishment of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trading plan by such stockholder pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of Common Stock; provided that such plan does
not provide for the transfer of Shares during the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period, and no public filing or other public announcement relating to the establishment of such plan is voluntarily made or, if required to be made,
such public filing or other public announcement shall indicate that no sales will take place during the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period, and such plan is otherwise permitted to be implemented during the <FONT
STYLE="white-space:nowrap">Lock-up</FONT> Period pursuant to the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement between such stockholder and the Underwriters in connection with the offering of the Offered Shares, or
(E)&nbsp;issue Shares or Related Securities in connection with bona fide mergers or acquisitions, business combinations, joint ventures or other strategic relationships (including the filing of a registration statement on Form <FONT
STYLE="white-space:nowrap">S-4</FONT> or other appropriate form with respect thereto), provided, that the aggregate number of Shares or Related Securities that the Company may sell or issue or agree to sell or issue pursuant to this clause
(E)&nbsp;shall not exceed 5% of the total number of shares of the Company&#146;s common stock issued and outstanding immediately following the completion of the transactions contemplated by this Agreement. For purposes of the foregoing,
&#147;<B>Related Securities</B>&#148; shall mean any options or warrants or other rights to acquire Shares or any securities exchangeable or exercisable for or convertible into Shares, or to <I>acquire</I> other securities or rights ultimately
exchangeable or exercisable for, or convertible into, Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(q) </B><B><I>Investment Limitation</I></B><B>.</B> The Company shall
not invest or otherwise use the proceeds received by the Company from its sale of the Offered Shares in such a manner as would require the Company or any of its subsidiaries to register as an investment company under the Investment Company Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(r) </B><B><I>No Stabilization or Manipulation</I></B><B><I>; Compliance with Regulation M</I></B><B>.</B> The Company will not take, and
will ensure that no affiliate of the Company will take, directly or indirectly, any action designed to or that might reasonably be expected to cause or result in stabilization or manipulation of the price of the Shares or any reference security with
respect to the Shares, whether to facilitate the sale or resale of the Offered Shares or otherwise, and the Company will, and shall cause each of its affiliates to, comply with all applicable provisions of Regulation M. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(s) </B><B><I>Enforce <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</I></B><B><I>s</I></B><B>.</B> During the <FONT
STYLE="white-space:nowrap">Lock-up</FONT> Period, the Company will enforce all agreements between the Company and any of its security holders that restrict or prohibit, expressly or in operation, the offer, sale or transfer of Shares or Related
Securities or any of the other actions restricted or prohibited under the terms of the form of <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement. In addition, the Company will direct the transfer agent to place stop transfer restrictions
upon any such securities of the Company that are bound by such <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreements for the duration of the periods contemplated in such agreements, including, without limitation, <FONT
STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreements entered into by the Company&#146;s officers and directors pursuant to Section&nbsp;6(j) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(t) </B><B><I>FinCEN</I></B><B>.</B> The Company will deliver to each Underwriter (or its agent), on or prior to the date of execution of
this Agreement, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of identifying documentation, and the Company undertakes to provide such additional supporting documentation
as each Underwriter may reasonably request in connection with the verification of the foregoing Certification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>B.
</B><B><I>[Reserved]. </I></B><B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;4. </B><B>Payment of Expenses</B><B>.</B> The Company agrees to pay
all costs, fees and expenses incurred in connection with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including without limitation (i)&nbsp;all expenses incident to the issuance and
delivery of the Offered Shares (including all printing and engraving costs), (ii)&nbsp;all fees and expenses of the registrar and transfer agent of the Shares, (iii)&nbsp;all necessary issue, transfer and other stamp taxes in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the issuance and sale of the Offered Shares to the Underwriters, (iv)&nbsp;all fees and expenses of the Company&#146;s counsel, independent public or certified public accountants
and other advisors, (v)&nbsp;all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and
certificates of experts), the Time of Sale Prospectus, the Prospectus, each free writing prospectus prepared by or on behalf of, used by, or referred to by the Company, and each preliminary prospectus, and all amendments and supplements thereto, and
this Agreement, (vi)&nbsp;all filing fees, attorneys&#146; fees and expenses incurred in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Offered Shares for offer
and sale under the state securities or blue sky laws or the provincial securities laws of Canada, and, if requested by the Representatives, preparing and printing a &#147;Blue Sky Survey&#148; or memorandum and a &#147;Canadian wrapper&#148; (such
&#147;Blue Sky Survey&#148; or memorandum and &#147;Canadian wrapper&#148;, fees and expenses of counsel in the aggregate amount not to exceed $10,000), and any supplements thereto, advising the Underwriters of such qualifications, registrations and
exemptions, (vii)&nbsp;the costs, fees and expenses incurred by the Underwriters in connection with determining their compliance with the rules and regulations of FINRA related to the Underwriters&#146; participation in the offering and distribution
of the Offered Shares, including any related filing fees and the legal fees of, and disbursements by, counsel to the Underwriters in any amount not to exceed $25,000, (viii)&nbsp;the costs and expenses of the Company relating to investor
presentations on any &#147;road show&#148;, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics, fees and
expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the representatives, employees and officers of the Company and any such consultants, and 50% of
the cost of any aircraft chartered in connection with the road show, with the remaining 50% of the cost of such aircraft being paid by the Underwriters, provided that the Company and the Representatives agree in advance to the charter of any
aircraft (ix)&nbsp;the fees and expenses associated with listing the Offered Shares on Nasdaq, and (x)&nbsp;all other fees, costs and expenses of the nature referred to in Item 14 of Part&nbsp;II of the Registration Statement. Except as provided in
this Section&nbsp;4 or in Section&nbsp;7, Section&nbsp;9 or Section&nbsp;10 hereof, the Underwriters shall pay their own expenses, including the fees and disbursements of their counsel and the travel and lodging expenses of their representatives and
employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5. </B><B>Covenant of the Underwriters</B><B>.</B> Each Underwriter severally and not jointly
covenants with the Company not to take any action that would result in the Company being required to file with the Commission pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter
that otherwise would not, but for such actions, be required to be filed by the Company under Rule 433(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6. </B><B>Conditions of the Obligations of the Underwriters</B><B>.</B> The respective obligations of the
several Underwriters hereunder to purchase and pay for the Offered Shares as provided herein on the First Closing Date and, with respect to the Optional Shares, each Option Closing Date, shall be subject to the accuracy of the representations and
warranties on the part of the Company set forth in Section&nbsp;1 hereof as of the date hereof and as of the First Closing Date as though then made and, with respect to the Optional Shares, as of each Option Closing Date as though then made, to the
performance by the Company of their covenants and other obligations hereunder, and to each of the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)
</B><B><I>Comfort Letter</I></B><B><I>s</I></B><B>.</B> On the date hereof, the Representatives shall have received from PricewaterhouseCoopers LLP, independent registered public accountants for the Company, a letter dated the date hereof addressed
to the Underwriters, in form and substance satisfactory to the Representatives, containing statements and information of the type ordinarily included in accountant&#146;s &#147;comfort letters&#148; to underwriters, delivered according to Statement
of Auditing Standards No.&nbsp;72 (or any successor bulletin), with respect to the audited and unaudited financial statements and certain financial information contained in the Registration Statement, the Time of Sale Prospectus, and each free
writing prospectus, if any. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><I>Compliance with Registration Requirements; No Stop Order; No Objection from
</I></B><B><I>FINRA</I></B><B><I>. </I></B>For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Optional Shares purchased after the First Closing Date, each Option Closing
Date: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Company shall have filed the Prospectus with the Commission (including the information previously omitted
from the Registration Statement pursuant to Rule 430B under the Securities Act) in the manner and within the time period required by Rule 424(b) under the Securities Act; or the Company shall have filed a
<FONT STYLE="white-space:nowrap">post-effective</FONT> amendment to the Registration Statement containing the information previously omitted from the Registration Statement pursuant to such Rule 430B, and such post-effective amendment shall have
become effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) No stop order suspending the effectiveness of the Registration Statement or any post-effective
amendment to the Registration Statement shall be in effect, and no proceedings for such purpose shall have been instituted or, to the knowledge of the Company, threatened by the Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) If a filing has been made with FINRA, FINRA shall have raised no objection to the fairness and reasonableness of the
underwriting terms and arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B><I>No Material Adverse Change or Ratings Agency Change</I></B><B>.</B> For the period
from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Optional Shares purchased after the First Closing Date, each Option Closing Date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) in the judgment of the Representatives there shall not have occurred any Material Adverse Change; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential
downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any securities of the Company or any of its subsidiaries by any &#147;nationally recognized statistical rating
organization&#148; as that term is used in <FONT STYLE="white-space:nowrap">Rule&nbsp;15c3-1(c)(2)(vi)(F)</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B><I>Opinion of Counsel for the Company</I></B><B>.</B> On each of the First Closing Date and each Option Closing Date the
Representatives shall have received the opinion, which shall include certain negative assurances, of Bass, Berry&nbsp;&amp; Sims PLC, counsel for the Company, dated as of such date, in a form and substance satisfactory to the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) </B><B><I>Opinion of Counsel for the Underwriters</I></B><B>.</B> On each of the First Closing Date and each Option Closing Date the
Representatives shall have received the opinion and negative assurance letter of Latham&nbsp;&amp; Watkins LLP, counsel for the Underwriters in connection with the offer and sale of the Offered Shares, in form and substance satisfactory to the
Underwriters, dated as of such date.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) </B><B><I>Officers</I></B><B><I>&#146;</I></B><B><I> Certificate</I></B><B>.</B> On
each of the First Closing Date and each Option Closing Date, the Representatives shall have received a certificate executed by the Chief Executive Officer or President of the Company and the Chief Financial Officer of the Company, dated as of such
date, to the effect set forth in Section&nbsp;6(b)(ii) and further to the effect that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) for the period from and
including the date of this Agreement through and including such date, there has not occurred any Material Adverse Change; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the representations, warranties and covenants of the Company set forth
in Section&nbsp;1A of this Agreement are true and correct with the same force and effect as though expressly made on and as of such date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Company has complied with all the agreements hereunder and satisfied all the conditions on its part to be performed
or satisfied hereunder at or prior to such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) </B><B><I>Bring-down Comfort Letter</I></B><B><I>s</I></B><B>.</B> On each of the
First Closing Date and each Option Closing Date the Representatives shall have received from PricewaterhouseCoopers LLP, independent registered public accountants for the Company, a letter dated such date, in form and substance satisfactory to the
Representatives, which letter shall: (i)&nbsp;reaffirm the statements made in the letter furnished by them pursuant to Section&nbsp;6(a), except that the specified date referred to therein for the carrying out of procedures shall be no more than
three business days prior to the First Closing Date or the applicable Option Closing Date, as the case may be; and (ii)&nbsp;cover certain financial information contained in the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h) </B><B><I>CFO Certificate.</I></B> The Underwriters shall have received, on each of the date hereof, the First Closing Date and each
Option Closing Date, a certificate of the Company&#146;s chief financial officer dated the date hereof or the First Closing Date or Option Closing Date, as the case may be, with respect to certain financial data contained in the Preliminary
Prospectus and the Prospectus, as the case may be, providing &#147;management comfort&#148; with respect to such information, in form and substance previously agreed to by the Company and the Representatives.<B><I> </I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i) </B><B><I>[Reserved]. </I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j) </B><B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</I></B><B><I>.</I></B> On or prior to the date hereof, the Company
shall have furnished to the Representatives an agreement in the form of <U>Exhibit A</U> hereto from each of the persons listed on Exhibit B hereto, and each such agreement shall be in full force and effect on each of the First Closing Date and each
Option Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k) </B><B><I>Rule</I></B><B><I></I></B><B><I>&nbsp;462(b) Registration Statement</I></B>. In the event that a
Rule&nbsp;462(b) Registration Statement is filed in connection with the offering contemplated by this Agreement, such Rule&nbsp;462(b) Registration Statement shall have been filed with the Commission on the date of this Agreement and shall have
become effective automatically upon such filing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l) </B><B><I>Additional Documents</I></B>. On or before each of the First Closing
Date and each Option Closing Date, the Representatives and counsel for the Underwriters shall have received such information, documents and opinions as they may reasonably request for the purposes of enabling them to pass upon the issuance and sale
of the Offered Shares as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained; and all proceedings taken by the Company
in connection with the issuance and sale of the Offered Shares as contemplated herein and in connection with the other transactions contemplated by this Agreement shall be satisfactory in form and substance to the Representatives and counsel for the
Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any condition specified in this Section&nbsp;6 is not satisfied when and as required to be satisfied, this Agreement may
be terminated by the Representatives by notice from the Representatives to the Company at any time on or prior to the First Closing Date and, with respect to the Optional Shares, at any time on or prior to the applicable Option Closing Date, which
termination shall be without liability on the part of any party to any other party, except that Section&nbsp;4, Section&nbsp;7, Section&nbsp;9 and Section&nbsp;10 shall at all times be effective and shall survive such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7. </B><B>Reimbursement of Underwriters</B><B>&#146;</B><B>
Expenses</B>. If this Agreement is terminated by the Representatives pursuant to Section&nbsp;6, Section&nbsp;11 or Section&nbsp;12, or if the sale to the Underwriters of the Offered Shares on the First Closing Date is not consummated because of any
refusal, inability or failure on the part of the Company to perform any agreement herein or to comply with any provision hereof, the Company agrees to reimburse the Representatives and the other Underwriters (or such Underwriters as have terminated
this Agreement with respect to themselves), severally, upon demand for all documented accountable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses that shall have been actually incurred and
documented by the Representatives and the Underwriters in connection with the proposed purchase and the offering and sale of the Offered Shares, including, but not limited to, fees and disbursements of counsel, printing expenses, travel expenses,
postage, facsimile and telephone charges. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;8. </B><B>Effectiveness of this Agreement</B>. This Agreement
shall become effective upon&nbsp;the execution and delivery hereof by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.
</B><B>Indemnification</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B><B><I>Indemnification of the Underwriters</I></B><B><I> by the Company</I></B><B>.</B> The Company
agrees to indemnify and hold harmless each Underwriter, its affiliates, directors, officers, employees and agents, and each person, if any, who controls any Underwriter within the meaning of the Securities Act or the Exchange Act against any loss,
claim, damage, liability or expense, as incurred, to which such Underwriter or such affiliate, director, officer, employee, agent or controlling person may become subject, under the Securities Act, the Exchange Act, other federal or state statutory
law or regulation, or the laws or regulations of foreign jurisdictions where Offered Shares have been offered or sold or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent
of the Company), insofar as such loss, claim, damage, liability or expense (or actions in respect thereof as contemplated below) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in
the Registration Statement, or any amendment thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; or (ii)&nbsp;any untrue statement or
alleged untrue statement of a material fact included in any preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule 433(d) of the
Securities Act, any Marketing Material or the Prospectus (or any amendment or supplement to the foregoing), or the omission or alleged omission to state therein a material fact necessary in order to make the statements, in the light of the
circumstances under which they were made, not misleading; or (iii)&nbsp;any act or failure to act or any alleged act or failure to act by any Underwriter in connection with, or relating in any manner to, the Offered Shares or the offering
contemplated hereby, and which is included as part of or referred to in any loss, claim, damage, liability or action arising out of or based upon any matter covered by clause (i)&nbsp;or (ii) above; and to reimburse each Underwriter and each such
affiliate, director, officer, employee, agent and controlling person for any and all reasonable and documented expenses (including the fees and disbursements of counsel) as such expenses are reasonably incurred by such Underwriter or such affiliate,
director, officer, employee, agent or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action; <I>provided, however</I>, that the foregoing indemnity
agreement shall not apply to any loss, claim, damage, liability or expense to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and
in conformity with information relating to any Underwriter furnished to the Company by the Representatives in writing expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any such free writing
prospectus, any Marketing Material or the Prospectus (or any amendment or supplement thereto), it being understood and agreed that the only such information consists of the information described in Section&nbsp;9(c) below. The indemnity agreement
set forth in this Section&nbsp;9(a) shall be in addition to any liabilities that the Company may otherwise have. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B><B><I>[Reserved]</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) </B><B><I>Indemnification of the Company, its Directors and Officers</I></B>. Each Underwriter agrees, severally and not jointly, to
indemnify and hold harmless the Company, each of its directors, each of its officers who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act, against any
loss, claim, damage, liability or expense, as incurred, to which the Company, or any such director, officer, or controlling person may become subject, under the Securities Act, the Exchange Act, or other federal or state statutory law or regulation,
or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of such Underwriter), insofar as such loss, claim, damage, liability or expense (or actions in respect thereof as
contemplated below) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or any amendment thereto, or any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact included in any preliminary prospectus, the Time of Sale
Prospectus, any free writing prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule 433 of the Securities Act or the Prospectus (or any such amendment or supplement) or the omission or alleged omission
to state therein a material fact necessary in order to make the statements, in the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission was made in the Registration Statement, such preliminary prospectus, the Time of Sale Prospectus, such free writing prospectus or the Prospectus (or any such amendment or supplement), in reliance upon
and in conformity with information relating to such Underwriter furnished to the Company by the Representatives in writing expressly for use therein; and to reimburse the Company, or any such director, officer, or controlling person for any and all
reasonable and documented expenses (including the fees and disbursements of counsel) as such expenses are reasonably incurred by the Company, or any such director, officer, or controlling person in connection with investigating, defending, settling,
compromising or paying any such loss, claim, damage, liability, expense or action. The Company hereby acknowledges that the only information that the Representatives have furnished to the Company expressly for use in the Registration Statement, any
preliminary prospectus, the Time of Sale Prospectus, any free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) of the Securities Act or the Prospectus (or any amendment or supplement to the foregoing)
are the statements set forth in the first sentence of the first paragraph under &#147;Commissions and Discounts&#148;, the second, third and fourth paragraphs under<B> </B>&#147;Price Stabilization, Short Position&#148;, the paragraph under the
heading &#147;Passive Market Making&#148; and the paragraph under the heading &#147;Electronic Distribution&#148; under the caption &#147;Underwriting (Conflicts of Interest)&#148; in the Preliminary Prospectus Supplement and the Final Prospectus
Supplement. The indemnity agreement set forth in this Section&nbsp;9(c) shall be in addition to any liabilities that each Underwriter may otherwise have. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B><B><I>Notifications and Other Indemnification Procedures</I></B><B>.</B> Promptly after receipt by an indemnified party under this
Section&nbsp;9 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this Section&nbsp;9, notify the indemnifying party in writing of the
commencement thereof, but the omission to so notify the indemnifying party will not relieve the indemnifying party from any liability which it may have to any indemnified party to the extent the indemnifying party is not materially prejudiced as a
proximate result of such failure and shall not in any event relieve the indemnifying party from any liability that it may have otherwise than on account of this indemnity agreement. In case any such action is brought against any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in, and, to the extent that it
shall elect, jointly with all other indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel
reasonably satisfactory to such indemnified party; <I>provided, however</I>, that if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that a
conflict may arise between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified parties which are different from
or additional to those available to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such
indemnified party or parties. Upon receipt of notice from the indemnifying party to such indemnified party of such indemnifying party&#146;s election to so assume the defense of such action and approval by the indemnified party of counsel, the
indemnifying party will not be liable to such indemnified party under this Section&nbsp;9 for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless (i)&nbsp;the indemnified party
shall have employed separate counsel in accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the fees and expenses of more than one separate counsel (together with
local counsel), representing the indemnified parties who are parties to such action), which counsel (together with any local counsel) for the indemnified parties shall be selected by the Representatives (in the case of counsel for the indemnified
parties referred to in Section&nbsp;9(c) above) or by the Company (in the case of counsel for the indemnified parties referred to in Section&nbsp;9(a) above)) or (ii)&nbsp;the indemnifying party shall not have employed counsel satisfactory to the
indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the action or (iii)&nbsp;the indemnifying party has authorized in writing the employment of counsel for the indemnified party at the
expense of the indemnifying party, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party and shall be paid as they are incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) </B><B><I>Settlements</I></B><B>.</B> The indemnifying party under this Section&nbsp;9 shall not be liable for any settlement of any
proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or
expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as
contemplated by Section&nbsp;9(d) hereof, the indemnifying party shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30&nbsp;days after receipt by such
indemnifying party of the aforesaid request and (ii)&nbsp;such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party shall, without the prior
written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party and
indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such
action, suit or proceeding and does not include an admission of fault or culpability or a failure to act by or on behalf of such indemnified party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) </B>[Reserved]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;10. </B><B>Contribution</B>. If the indemnification provided for in Section&nbsp;9 is for any reason held to be
unavailable to or otherwise insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount paid or
payable by such indemnified party, as incurred, as a result of any losses, claims, damages, liabilities or expenses referred to therein (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company, on the
one hand, and the Underwriters, on the other hand, from the offering of the Offered Shares pursuant to this Agreement or (ii)&nbsp;if the allocation provided by clause&nbsp;(i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause&nbsp;(i) above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, in connection with the statements or omissions which
resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, in connection with
the offering of the Offered Shares pursuant to this Agreement shall be deemed to be in the same respective proportions as the net proceeds from the offering of the Offered Shares pursuant to this Agreement (before deducting expenses) received by the
Company and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth on the front cover page of the Prospectus, bear to the aggregate Public Offering Price of the Offered Shares as set forth on such
cover. The relative fault of the Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or
alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Underwriters, on the other hand, and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount paid or payable by a party as a result of the losses, claims, damages, liabilities and
expenses referred to above shall be deemed to include, subject to the limitations set forth in Section&nbsp;9(d), any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending any action or
claim. The provisions set forth in Section&nbsp;9(d) with respect to notice of commencement of any action shall apply if a claim for contribution is to be made under this Section&nbsp;10; <I>provided, however,</I> that no additional notice shall be
required with respect to any action for which notice has been given under Section&nbsp;9(d) for purposes of indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company
and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;10 were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method
of allocation which does not take account of the equitable considerations referred to in this Section&nbsp;10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
provisions of this Section&nbsp;10, no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions received by such Underwriter in connection with the Offered Shares underwritten by it and
distributed to the public. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
The Underwriters&#146; obligations to contribute pursuant to this Section&nbsp;10 are several, and not joint, in proportion to their respective underwriting commitments as set forth opposite their respective names on <U>Schedule A</U>. For purposes
of this Section&nbsp;10, each affiliate, director, officer, employee and agent of an Underwriter and each person, if any, who controls an Underwriter within the meaning of the Securities Act or the Exchange Act shall have the same rights to
contribution as such Underwriter, and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of the Securities Act and the Exchange Act
shall have the same rights to contribution as the Company. The remedies provided for in this Section&nbsp;10 and Section&nbsp;9 of this Agreement are not exclusive and shall not limit any rights or remedies which may otherwise be available to any
indemnified party at law or equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;11. </B><B>Default of One or More of the Several
Underwriters</B><I>.</I> If, on the First Closing Date or any Option Closing Date any one or more of the several Underwriters shall fail or refuse to purchase Offered Shares that it or they have agreed to purchase hereunder on such date, and the
aggregate number of Offered Shares which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase does not exceed 10% of the aggregate number of the Offered Shares to be purchased on such date, the Representatives may
make arrangements satisfactory to the Company for the purchase of such Offered Shares by other persons, including any of the Underwriters, but if no such arrangements are made by such date, the other Underwriters shall be obligated, severally and
not jointly, in the proportions that the number of Firm Shares set forth opposite their respective names on <U>Schedule</U><U> A</U> bears to the aggregate number of Firm Shares set forth opposite the names of all such
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or in such other proportions as may be specified by the Representatives with the consent of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, to purchase the
Offered Shares which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date. If, on the First Closing Date or any Option Closing Date any one or more of the Underwriters shall fail or refuse to purchase
Offered Shares and the aggregate number of Offered Shares with respect to which such default occurs exceeds 10% of the aggregate number of Offered Shares to be purchased on such date, and arrangements satisfactory to the Representatives and the
Company for the purchase of such Offered Shares are not made within 48 hours after such default, this Agreement shall terminate without liability of any party to any other party except that the provisions of Section&nbsp;4, Section&nbsp;7,
Section&nbsp;9 and Section&nbsp;10 shall at all times be effective and shall survive such termination. In any such case either the Representatives or the Company shall have the right to postpone the First Closing Date or the applicable Option
Closing Date, as the case may be, but in no event for longer than seven days in order that the required changes, if any, to the Registration Statement and the Prospectus or any other documents or arrangements may be effected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Agreement, the term &#147;<B>Underwriter</B>&#148; shall be deemed to include any person substituted for a defaulting
Underwriter under this Section&nbsp;11. Any action taken under this Section&nbsp;11 shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;12. </B><B>Termination of this Agreement</B><I>.</I> Prior to the purchase of the Firm Shares by the
Underwriters on the First Closing Date, this Agreement may be terminated by the Representatives by notice given to the Company if at any time: (i)&nbsp;trading or quotation in any of the Company&#146;s securities shall have been suspended or
materially limited by the Commission or by Nasdaq, or trading in securities generally on either Nasdaq or the NYSE shall have been suspended or materially limited, or minimum or maximum prices shall have been generally established on any of such
stock exchanges; (ii)&nbsp;a general banking moratorium shall have been declared by any of federal or New York authorities; (iii)&nbsp;there shall have occurred any outbreak or escalation of national or international hostilities or any crisis or
calamity, or any change in the United States or international financial markets, or any substantial change or development involving a prospective substantial change in United States&#146; or international political, financial or economic conditions,
as in the judgment of the Representatives is material and adverse and makes it impracticable to market the Offered Shares in the manner and on the terms described in the Time of Sale Prospectus or the Prospectus or to enforce contracts for the sale
of securities; or (iv)&nbsp;in the judgment of the Representatives there shall have occurred any Material Adverse Change. Any termination pursuant to this Section&nbsp;12 shall be without liability on the part of (a)&nbsp;the Company to any
Underwriter, except that the Company shall be obligated to reimburse the expenses of the Representatives and the Underwriters pursuant to Section&nbsp;4 or Section&nbsp;7&nbsp;hereof or (b)&nbsp;any Underwriter to the Company; <I>provided,
however,</I> that the provisions of Section&nbsp;9 and Section&nbsp;10 shall at all times be effective and shall survive such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;13. </B><B>No Advisory or Fiduciary Relationship. </B>The
Company acknowledges and agrees that (a)&nbsp;the purchase and sale of the Offered Shares pursuant to this Agreement, including the determination of the public offering price of the Offered Shares and any related discounts and commissions, is an <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, (b)&nbsp;in connection with the offering contemplated hereby and the process leading to
such transaction, each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company, or the Company&#146;s stockholders, or its creditors, employees or any other party, (c)&nbsp;no Underwriter has assumed
or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company
on other matters) and no Underwriter has any obligation to the Company with respect to the offering contemplated hereby except the obligations expressly set forth in this Agreement, (d)&nbsp;the Underwriters and their respective affiliates may be
engaged in a broad range of transactions that involve interests that differ from those of the Company, and (e)&nbsp;the Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby
and the Company has consulted their own legal, accounting, regulatory and tax advisors to the extent they deemed appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;14. Representations and Indemnities to Survive Delivery</B><I>.</I> The respective indemnities, agreements,
representations, warranties and other statements of the Company, of its officers, and of the several Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on
behalf of any Underwriter or the Company or any of its or their partners, officers or directors or any controlling person, or any controlling person, as the case may be, and, anything herein to the contrary notwithstanding, will survive delivery of
and payment for the Offered Shares sold hereunder and any termination of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;15.
</B><B>Notices</B>. All communications hereunder shall be in writing and shall be mailed, hand delivered or telecopied and confirmed to the parties hereto as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="72%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">If to the Representatives:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">BofA Securities, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">One Bryant Park</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York, New York 10036</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Facsimile: (646) <FONT STYLE="white-space:nowrap">291-1469</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attention: Syndicate Department</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email: dg.ecm_execution_services@bofa.com, with a copy to dg.ecm_legal@bofa.com</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jefferies LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">520 Madison Avenue</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York, New York 10022</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Facsimile: (646) <FONT STYLE="white-space:nowrap">619-4437</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attention: Equity Syndicate Department</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email: Prospectus_Department@Jefferies.com</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">with a copy to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Latham&nbsp;&amp; Watkins LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1271 Avenue of the Americas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York, NY 10020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Marc Jaffe, Alison Haggerty</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">If to the Company:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Addus HomeCare Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6303 Cowboys Way, Suite 600</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Frisco, TX</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Attn: Sean Gaffney</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">with a copy to:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bass, Berry&nbsp;&amp; Sims PLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">150 Third Avenue South, Suite 2800</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Nashville, TN 37201</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: David Cox</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any party hereto may change the address for receipt of communications by giving written notice to the
others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;16. </B><B>Successors</B><I>.</I> This Agreement will inure to the benefit of and be binding upon
the parties hereto, including any substitute Underwriters pursuant to Section&nbsp;11 hereof, and to the benefit of the affiliates, directors, officers, employees, agents and controlling persons referred to in Section&nbsp;9 and Section&nbsp;10, and
in each case their respective successors, and no other person will have any right or obligation hereunder. The term &#147;<B>successors</B>&#148; shall not include any purchaser of the Offered Shares as such from any of the Underwriters merely by
reason of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;17. </B><B>Partial Unenforceability</B>. The invalidity or unenforceability of any
section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision hereof. If any section, paragraph or provision of this Agreement is for any reason determined to be
invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;18. Recognition of the U.S. Special Resolution Regimes.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime,
the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and
any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>In the event
that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are
permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, (A) &#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be
interpreted in accordance with, 12 U.S.C. &#167; 1841(k); (B) &#147;<B>Covered Entity</B>&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&#167; 382.2(b); (C) &#147;<B>Default Right</B>&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and (D) &#147;<B>U.S. Special Resolution
Regime</B>&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;19. </B><B>Governing Law Provisions</B><I>.</I> This Agreement shall be governed by and construed in
accordance with the internal laws of the State of New York applicable to agreements made and to be performed in such state. Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby
(&#147;<B>Related Proceedings</B>&#148;) may be instituted in the federal courts of the United States of America located in the Borough of Manhattan in the City of New </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
York or the courts of the State of New York in each case located in the Borough of Manhattan in the City of New York (collectively, the &#147;<B>Specified Courts</B>&#148;), and each party
irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court (a &#147;<B>Related Judgment</B>&#148;), as to which such jurisdiction is <FONT
STYLE="white-space:nowrap">non-exclusive)</FONT> of such courts in any such suit, action or proceeding. Service of any process, summons, notice or document by mail to such party&#146;s address set forth above shall be effective service of process
for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and
unconditionally waive and agree not to plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;20. </B><B>General Provisions</B><B>.</B> This Agreement constitutes the entire agreement of the parties to this
Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or more counterparts, each one of which
shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or
implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. The section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the parties hereto acknowledges that it is a sophisticated business person who was adequately represented by counsel during
negotiations regarding the provisions hereof, including, without limitation, the indemnification provisions of Section&nbsp;9 and the contribution provisions of Section&nbsp;10, and is fully informed regarding said provisions. Each of the parties
hereto further acknowledges that the provisions of Section&nbsp;9 and&nbsp;Section 10 hereof fairly allocate the risks in light of the ability of the parties to investigate the Company, its affairs and its business in order to assure that adequate
disclosure has been made in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, each free writing prospectus and the Prospectus (and any amendments and supplements to the foregoing), as contemplated by the Securities
Act and the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding of our agreement, kindly sign and
return to the Company the enclosed copies hereof, whereupon this instrument, along with all counterparts hereof, shall become a binding agreement in accordance with its terms. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ADDUS HOMECARE CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ R. Dirk Allison</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: R. Dirk Allison</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing Underwriting Agreement is hereby confirmed and accepted by the Representatives
in New York, New York as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BOFA SECURITIES, INC.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>JEFFERIES LLC</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Acting individually and as Representatives of the several Underwriters named in the attached <U>Schedule A</U>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BOFA SECURITIES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Andreas Apostolatos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Andreas Apostolatos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>JEFFERIES LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Michael Bauer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Michael Bauer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Schedule A </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Underwriters</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Firm&nbsp;Shares</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to&nbsp;be&nbsp;Purchased</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">651,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jefferies LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">488,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Oppenheimer&nbsp;&amp; Co. Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond James&nbsp;&amp; Associates, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephens Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Schedule B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Reserved] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Schedule C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Free Writing Prospectuses Included in the Time of Sale Prospectus </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>None </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jefferies LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Representatives of the Several Underwriters </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Bryant Park </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Jefferies LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">520 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RE: &#8195;&#8194;Addus HomeCare Corporation (the &#147;<B>Company</B>&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies&nbsp;&amp; Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned is an owner of
shares of common stock, par value $0.001 per share, of the Company (&#147;<B>Shares</B>&#148;) or of securities convertible into or exchangeable or exercisable for Shares. The Company proposes to conduct a public offering of Shares (the
&#147;<B>Offering</B>&#148;) for which BofA Securities, Inc. (&#147;BofA&#148;) and Jefferies LLC (&#147;<B>Jefferies</B>&#148;) will act as the Representatives of the underwriters. The undersigned recognizes that the Offering will benefit each of
the Company and the undersigned. The undersigned acknowledges that the underwriters are relying on the representations and agreements of the undersigned contained in this letter agreement in conducting the Offering and, at a subsequent date, in
entering into an underwriting agreement (the &#147;<B>Underwriting Agreement</B>&#148;) and other underwriting arrangements with the Company with respect to the Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Annex A sets forth definitions for capitalized terms used in this letter agreement that are not defined in the body of this agreement. Those definitions are a
part of this agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned hereby agrees that, during the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period, the undersigned will not (and will use its reasonable best efforts to cause any Family Member not to), without the prior written
consent of (1)&nbsp;BofA and (2)&nbsp;Jefferies, which may withhold their consent in their sole discretion: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sell or Offer to Sell any Shares or Related Securities currently or hereafter owned either of record or
beneficially (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) by the undersigned or such Family Member, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into any Swap, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any demand for, or exercise any right with respect to, the registration under the Securities Act of the
offer and sale of any Shares or Related Securities, or cause to be filed a registration statement, prospectus or prospectus supplement (or an amendment or supplement thereto) with respect to any such registration, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publicly announce any intention to do any of the foregoing. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing will not apply to the registration of the offer and sale of the Shares, and the sale of the
Shares to the underwriters, in each case as contemplated by the Underwriting Agreement. In addition, notwithstanding the foregoing, the undersigned may transfer any or all of the Shares or Related Securities (i)&nbsp;as a bona fide gift or gifts or
charitable contribution(s), (ii) to any trust for the direct or indirect benefit of the undersigned or the immediate family member of the undersigned, (iii)&nbsp;if the undersigned is a corporation, partnership, limited liability company, trust or
other business entity, as transfers or distributions of Shares or Related Securities to partners, limited liability company members, stockholders of the undersigned, holders of similar equity interests in the undersigned, or any affiliate,
(iv)&nbsp;if the undersigned is a trust, to the beneficiary of such trust, (v)&nbsp;by testate succession or intestate succession, (vi)&nbsp;to any immediate family member, any investment fund, family partnership, family limited liability company or
other entity controlled or managed by the undersigned, (vii)&nbsp;to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i)&nbsp;through (vi), (viii) to the Company in a transaction
exempt from Section&nbsp;16(b) of the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;) upon a vesting event of the Shares or Related Securities or upon the exercise of options or warrants to purchase Shares on a
&#147;cashless&#148; or &#147;net exercise&#148; basis or to cover tax withholding obligations of the undersigned in connection with such vesting or exercise (but for the avoidance of doubt, excluding all manners of exercise that would involve a
sale in the open market of any securities relating to such options or warrants, whether to cover the applicable aggregate exercise price, withholding tax obligations or otherwise); provided that any Securities issued upon vesting or exercise shall
remain subject to the restrictions on transfer set forth herein, (ix)&nbsp;acquired by the undersigned in open market transactions after the date hereof, (x)&nbsp;pursuant to a bona fide third party tender offer, merger, consolidation or other
similar transaction made to all holders of the Company&#146;s capital stock involving a Change of Control of the Company, provided that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the Shares
or Related Securities shall remain subject to the restrictions contained in this Agreement, or (xi)&nbsp;by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement or any other court order;
provided, in the case of clauses (i)-(vii) and (xi), that the transferee agrees in writing to be bound by the terms of this Agreement; and provided, further, in the case of clauses (i)-(viii), prior to the expiration of the <FONT
STYLE="white-space:nowrap">Lock-up</FONT> Period, no public announcement or filing by any party under Section&nbsp;16(a) of the Exchange Act or otherwise shall be required or shall be made voluntarily reporting a reduction in beneficial ownership of
Shares in connection with such transfer, other than any required Form 4 filing as a result of a transfer pursuant to clause (i)&nbsp;or (viii) (in which case such Form 4 filing shall clearly indicate in the footnotes thereto the nature and
circumstances of such transfer). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the foregoing restrictions shall not apply to (i)&nbsp;the conversion or exercise of options or warrants
into Shares or into any other security convertible into or exercisable for Shares that are outstanding as of the date hereof (but for the avoidance of doubt, excluding all manners of conversion or exercise that would involve a sale in the open
market of any securities relating to such warrants, whether to cover the applicable aggregate exercise price, withholding tax obligations or otherwise); provided that the foregoing restrictions shall apply to any of the Securities issued upon such
conversion or exercise, or (ii)&nbsp;the establishment of any contract, instruction or plan (a &#147;<B>Plan</B>&#148;) that satisfies all of the requirements of Rule <FONT STYLE="white-space:nowrap">10b5-1(c)(1)(i)(B)</FONT> under the Exchange Act;
provided that no sales of the Securities shall be made pursuant to such a Plan prior to the expiration of the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, and such a Plan may only be established if no public announcement of the
establishment or existence thereof and no filing with the Securities and Exchange Commission or other regulatory authority in respect thereof or transactions thereunder or contemplated thereby, by the undersigned, the Company or any other person,
shall be made voluntarily, by the undersigned, the Company or any other person, prior to the expiration of the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, and if any such filing or announcement shall be legally required during
the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, such filing or public announcement shall indicate that no sales under such Plan will take place during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period; provided, further, in the
case of clauses (i)&#151;(ii) of this paragraph, prior to the expiration of the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Period, no public announcement or filing by any party under Section&nbsp;16(a) of the Exchange Act or otherwise shall be
required or shall be made voluntarily reporting a reduction in beneficial ownership of Shares in connection with such exercise or conversion. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#146;s
transfer agent and registrar against the transfer of Shares or Related Securities held by the undersigned and the undersigned&#146;s Family Members, if any, except in compliance with the foregoing restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned confirms that the undersigned has not, and has no knowledge that any Family Member has, directly or indirectly, taken any action designed to
cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale of the Shares. The undersigned will not, and will cause any Family Member not to take any such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the underwriters have not provided any recommendation or investment advice nor have the underwriters solicited
any action from the undersigned with respect to the Offering and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whether or not the Offering occurs as currently contemplated or at all depends on market conditions and other factors. The Offering will only be made pursuant
to the Underwriting Agreement, the terms of which are subject to negotiation between the Company and the underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned understands that
the Company and the Underwriters are relying upon this agreement in proceeding toward consummation of the Offering. The undersigned further understands that this agreement is irrevocable and will be binding on the undersigned and the successors,
heirs, legal representatives and assigns of the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter agreement will automatically terminate upon the earliest to occur, if any, of
(a)&nbsp;the date the Company advises the Representatives in writing, prior to the execution of the Underwriting Agreement, that it has determined not to proceed with the Offering, (b)&nbsp;the date of the termination of the Underwriting Agreement
if prior to the closing of the Offering and (c)&nbsp;July&nbsp;19, 2024 if the Underwriting Agreement has not been executed by such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter
agreement shall be governed by, and construed in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter agreement may be delivered via
facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com) or other transmission method, and any counterpart so delivered shall be deemed to
have been duly and validly delivered and be valid and effective for all purposes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printed Name of Person Signing</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>(Indicate capacity of person signing if signing as custodian or trustee, or on behalf of an entity)</I></TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain Defined Terms </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Used in <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the letter agreement to which this Annex A is attached and of which it is made a part: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Call Equivalent Position</B>&#148;<B> </B>shall have the meaning set forth in Rule <FONT
STYLE="white-space:nowrap">16a-1(b)</FONT> under the Exchange Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Change of Control&#148; means the consummation of any bona fide third party tender offer, merger,
consolidation or other similar transaction after the Offering and approved by the Board of Directors of the Company, the result of which is that any &#147;person&#148; (as defined in Section&nbsp;13(d)(3) of the Exchange Act), or group of persons,
other than the Company or its subsidiaries, becomes the beneficial owner (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> of the Exchange Act) of 90% of the total voting power of
the voting stock of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Exchange Act</B>&#148;<B> </B>shall mean the Securities Exchange Act of 1934, as amended.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Family Member</B>&#148; shall mean the spouse of the undersigned, an immediate family member of the
undersigned or an immediate family member of the undersigned&#146;s spouse, in each case living in the undersigned&#146;s household or whose principal residence is the undersigned&#146;s household (regardless of whether such spouse or family member
may at the time be living elsewhere due to educational activities, health care treatment, military service, temporary internship or employment or otherwise). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Immediate family member</B>&#148; as used above shall have the meaning set forth in Rule <FONT
STYLE="white-space:nowrap">16a-1(e)</FONT> under the Exchange Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Period</B>&#148; shall mean the period beginning on the
date hereof and continuing through the close of trading on the date that is 60 days after the date of the Prospectus (as defined in the Underwriting Agreement). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Put Equivalent Position</B>&#148; shall have the meaning set forth in Rule <FONT
STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Related Securities</B>&#148; shall mean any options or warrants or other rights to acquire Shares or any
securities exchangeable or exercisable for or convertible into Shares, or to acquire other securities or rights ultimately exchangeable or exercisable for or convertible into Shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Securities Act</B>&#148; shall mean the Securities Act of 1933, as amended. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Sell or Offer to Sell</B>&#148; shall mean to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell, offer to sell, contract to sell or lend, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effect any short sale or establish or increase a Put Equivalent Position or liquidate or decrease any Call
Equivalent Position </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pledge, hypothecate or grant any security interest in, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other way transfer or dispose of, </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">in each case whether effected directly or indirectly. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<B>Swap</B>&#148; shall mean any swap, hedge or similar arrangement or agreement that transfers, in whole
or in part, the economic risk of ownership of Shares or Related Securities, regardless of whether any such transaction is to be settled in securities, in cash or otherwise. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Capitalized terms not defined in this Annex A shall have the meanings given to them in the body of this <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Directors, Officers and Others </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>&#8195;&#8195;&#8195;Signing <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement&#8195;&#8195;&#8195;&#8195; </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Directors: </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">R. Dirk Allison </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mark L. First </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Darin J. Gordon </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Esteban L&oacute;pez, M.D. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jean Rush </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Susan T. Weaver, M.D., FACP </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Heather Dixon </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Michael Earley </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Veronica Hill-Milbourne </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Officers: </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Brian Poff </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">W. Bradley Bickham </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Darby Anderson </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sean Gaffney </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cliff Blessing </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Monica Raines </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Roberton Stevenson </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">David Tucker </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Michael Wattenbarger </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d805293dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805293g0626210403025.jpg" ALT="LOGO" STYLE="width:3.59444in;height:0.392361in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 Third Avenue South, Suite 2800 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nashville, TN&nbsp;37201 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(615) <FONT
STYLE="white-space:nowrap">742-6200</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">June&nbsp;26, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Addus HomeCare Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6303 Cowboys Way, Suite 600 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Frisco, Texas 75034 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to Addus HomeCare Corporation, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection with the
Prospectus Supplement, dated June&nbsp;26, 2024, as filed on June&nbsp;28, 2024 (the &#147;<B><I>Prospectus Supplement</I></B>&#148;), filed under the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> Registration
No.&nbsp;333-267253 (the &#147;<B><I>Registration Statement</I></B>&#148;), of the Company pursuant to the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;), relating to (i)&nbsp;the sale by the Company of
1,500,000<B> </B>shares (the &#147;<B><I>Firm Shares</I></B>&#148;) of the Company&#146;s common stock, par value $0.001 per share (&#147;<B><I>Common Stock</I></B>&#148;) and (ii)&nbsp;the sale by the Company, at the option of the Underwriters, of
up to 225,000 additional shares of Common Stock (the &#147;<B><I>Optional Shares</I></B>&#148; and, collectively with the Firm Shares, the &#147;<B><I>Shares</I></B>&#148;), pursuant to the Underwriting Agreement, dated June&nbsp;26, 2024 (the
<I>&#147;</I><B><I>Underwriting Agreement</I></B>&#148;), by and among the Company and BofA Securities, Inc. and Jefferies LLC, acting individually and as Representatives of the several Underwriters named in <U>Schedule A</U> to the Underwriting
Agreement (the &#147;<B><I>Underwriters</I></B>&#148;). This opinion is being furnished in connection with the requirements of Item&nbsp;601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have reviewed the Registration Statement and the Prospectus Supplement. We have also reviewed such
corporate documents and records of the Company and such other matters as we have deemed necessary or appropriate for purposes of this opinion. As to various issues of fact, we have relied upon the representations and statements of fact made in the
documents that we have reviewed, and have made no independent verification or investigation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed that all documents we have
reviewed are the valid and binding obligations of and enforceable against the parties thereto. We have also assumed the authenticity of all documents submitted to us as originals, the genuineness of all signatures, the conformity to authentic
original documents of all documents submitted to us as certified, facsimile, conformed, digitally scanned or photostatic copies and the legal capacities of all natural persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, and subject to the assumptions, limitations and qualifications set forth herein, we are of the opinion that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The Firm Shares have been duly authorized and, when issued and delivered by the Company against payment of the consideration set forth in
the Underwriting Agreement, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The
Optional Shares have been duly authorized, and assuming the due and proper exercise of the Underwriters&#146; option in accordance with the terms of the Underwriting Agreement and, when issued and delivered by the Company pursuant to the
Underwriting Agreement against payment of the consideration set forth therein, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Addus HomeCare Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;26, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions as set forth herein are limited in all respects to the federal laws of the
United States of America and the General Corporation Law of the State of Delaware. No opinion is given regarding the laws of any other jurisdiction. We express no opinion with respect to the registration or qualification of the Shares under any
state securities or &#147;Blue Sky&#148; laws. The opinions expressed in this opinion are strictly limited to the matters stated in this opinion and no other opinions are to be implied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter is rendered as of the date hereof and we assume no responsibility to update this letter for changes in law or fact (or the effect
thereof on the opinions expressed herein) that hereafter may come to our attention. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an
exhibit to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated as of June&nbsp;28, 2024, and to the deemed incorporation by reference of this opinion into the Registration Statement and the references to our
firm therein and in the Prospectus Supplement. In giving this consent, we do not admit that we are &#147;experts&#148; within the meaning of Section&nbsp;11 of the Securities Act, or within the category of persons whose consent is required by
Section&nbsp;7 of the Securities Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Bass, Berry&nbsp;&amp; Sims PLC</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d805293dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805293dsp006.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contacts:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian W. Poff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dru Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Executive Vice President,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FINN Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;Chief Financial Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(615) <FONT STYLE="white-space:nowrap">324-7346</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Addus HomeCare Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>dru.anderson@finnpartners.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(469) <FONT STYLE="white-space:nowrap">535-8200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>investorrelations@addus.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDUS HOMECARE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Frisco, Texas (June 26, 2024) &#150; </B>Addus HomeCare Corporation (Nasdaq: ADUS) (&#147;Addus&#148; or the &#147;Company&#148;), a provider of home care
services, today announced that it has commenced a proposed public offering of 1,500,000 shares of its common stock. Addus expects to grant the underwriters a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase<B> </B>additional<B>
</B>shares of its common stock in an amount of up to 225,000 shares of its common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities and Jefferies are acting as joint book-running
managers for the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the final size or terms of the offering. Addus intends to use approximately
$81.4&nbsp;million of the net proceeds it receives from this offering for the repayment of all indebtedness outstanding under its credit facility and the remainder for general corporate purposes, including the Company&#146;s previously announced
acquisition of the personal care assets of Gentiva and any future acquisitions or investments. There are no selling stockholders in the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An
automatic shelf registration statement (including a prospectus) relating to the offering of common stock was filed with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;) on September&nbsp;2, 2022, and became effective upon filing.
This offering will be made only by means of a prospectus supplement and the accompanying prospectus that forms a part of the effective shelf registration statement. A preliminary prospectus supplement, dated June 26, 2024, and accompanying
prospectus, dated September&nbsp;2, 2022, relating to the offering will be filed with the SEC. Investors are advised to carefully consider the investment objectives, risks and charges and expenses of Addus described therein before investing. To
obtain a copy of the preliminary prospectus supplement, dated June 26, 2024, and the final prospectus supplement (when available) for this offering, please contact<B> </B>BofA Securities, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NC1-022-02-25,</FONT></FONT></FONT> Attn: Prospectus Department, 201 North Tryon Street, Charlotte, NC 28255, or by emailing dg.prospectus_requests@bofa.com, or Jefferies LLC, Attn: Equity
Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, or by telephone at (877) <FONT STYLE="white-space:nowrap">821-7388,</FONT> or by emailing <U>Prospectus_Department@Jefferies.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these
securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Addus </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Addus is a provider of home care services
that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus&#146; consumers are primarily persons who, without these services, are at risk of hospitalization or
institutionalization, such as the elderly, chronically ill and disabled. Addus&#146; payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals. Addus currently
provides home care services to approximately 49,000 consumers through 214 locations across 22 states. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-MORE- </P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADUS Announces Proposed Public Offering of Common Stock </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 26,<B> </B>2024 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain matters discussed in this press release, including those relating to the timing, size and other terms of the offering, including the proposed use of
proceeds from the offering, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as &#147;will,&#148; &#147;continue,&#148;
&#147;expect,&#148; &#147;believe&#148; and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a
number of risks and uncertainties that may cause actual results and the timing of certain events to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, the following: the impact of
macroeconomic conditions, including significant global inflation and elevated interests rates, legislative developments, trade disruptions and the potential adverse effects of current geopolitical conditions; business disruptions due to natural
disasters, acts of terrorism, pandemics, riots, civil insurrection or social unrest, looting, protests, strikes or street demonstrations; changes in operational and reimbursement processes and payment structures at the state or federal levels;
changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates, and the timeliness of reimbursements received under government programs; changes in, or our failure to comply with existing, federal
and state laws or regulations or our failure to comply with new government laws or regulations on a timely basis; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and
payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system
reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and
retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to the
overall economic conditions and deficit reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our
ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches,
cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of
the markets for our services, including our expectations regarding the market for our services; eligibility standards and limits on services imposed by state governmental agencies; the potential for litigation, audits and investigations;
discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating and integrating acquisition opportunities, and expand
into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality and cost of our services; our ability to
successfully execute our growth strategy; changes in tax rates; the impact of inclement weather or natural disasters; and various other matters, and other risks set forth in the section titled &#147;Risk Factors&#148; in our&nbsp;periodic reports
filed with the SEC, including, but not limited to, the our&nbsp;Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023, and our other filings with the SEC, including the preliminary
prospectus supplement and the final prospectus supplement (when available). We caution readers not to place undue reliance on any such forward-looking statements which speak only as of the date made. Except as required by law, we undertake no
obligation to update or revise any forward-looking statements that it makes in its press releases, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-END- </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>d805293dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g805293dsp006.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Contacts:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian W. Poff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dru Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Executive Vice President,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FINN Partners</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#8195;Chief Financial Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(615) <FONT STYLE="white-space:nowrap">324-7346</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Addus HomeCare Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>dru.anderson@finnpartners.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(469) <FONT STYLE="white-space:nowrap">535-8200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>investorrelations@addus.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDUS HOMECARE ANNOUNCES PRICING OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PUBLIC OFFERING OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Frisco, Texas (June 26</B><B>, 2024</B><B>) &#150; </B>Addus HomeCare Corporation (Nasdaq: ADUS) (&#147;Addus&#148; or the &#147;Company&#148;), a provider
of home care services, today announced the pricing of an underwritten public offering of 1,500,000 shares of common stock (&#147;Common Stock&#148;) at the public offering price of $108.00<B> </B>per share. Addus has granted the underwriters a <FONT
STYLE="white-space:nowrap">30-day</FONT> option to purchase up to 225,000<B> </B>additional<B> </B>shares of Common Stock on the same terms and conditions. The gross proceeds to the Company from the offering, before deducting underwriting discounts
and commissions and estimated offering expenses, are expected to be $162&nbsp;million, excluding any proceeds from the exercise of the underwriters&#146; option to purchase additional shares from the Company. Addus intends to use approximately
$81.4&nbsp;million of the net proceeds it receives from this offering for the repayment of all indebtedness outstanding under its credit facility and the remainder for general corporate purposes, including the Company&#146;s previously announced
acquisition of the personal care assets of Gentiva and any future acquisitions or investments. There were no selling stockholders in the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA
Securities and Jefferies are acting as joint book-running managers for the offering and Oppenheimer&nbsp;&amp; Co., Raymond James, RBC Capital Markets and Stephens Inc. are acting as <FONT STYLE="white-space:nowrap">co-managers.</FONT> The offering
is expected to close on or about June 28, 2024, subject to customary closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An automatic shelf registration statement (including a
prospectus) relating to the offering of Common Stock was filed with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;) on September&nbsp;2, 2022, and became effective upon filing. This offering is being made only by means of a
prospectus supplement and the accompanying prospectus that forms a part of the effective shelf registration statement. A preliminary prospectus supplement relating to, and describing the terms of, the offering was filed with the SEC on June&nbsp;26,
2024 and is available on the SEC&#146;s website at <U>www.sec.gov</U>. The final prospectus supplement and the accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC&#146;s website at
<U>www.sec.gov</U>. When available, copies of the final prospectus supplement and the accompanying prospectus may also be obtained by request from<B> </B>BofA Securities <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">NC1-022-02-25,</FONT></FONT></FONT> Attn: Prospectus Department, 201 North Tryon Street, Charlotte, NC 28255, or by emailing <U>dg.prospectus_requests@bofa.com</U>, or Jefferies LLC, Attn: Equity Syndicate Prospectus
Department, 520 Madison Avenue, New York, NY 10022, or by telephone at (877) <FONT STYLE="white-space:nowrap">821-7388,</FONT> or by emailing <U>Prospectus_Department@Jefferies.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these
securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-MORE- </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADUS Announces Pricing of Public Offering of Common Stock </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;26, 2024 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Addus </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Addus is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and
home health services. Addus&#146; consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus&#146; payor clients include federal,
state and local governmental agencies, managed care organizations, commercial insurers and private individuals. Addus currently provides home care services to approximately 49,000 consumers through 214 locations across 22 states. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain matters discussed in this press release, including those relating to timing for completion of the offering and the use of proceeds from the
offering, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as &#147;will,&#148; &#147;continue,&#148;
&#147;expect,&#148; &#147;believe&#148; and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a
number of risks and uncertainties that may cause actual results and the timing of certain events to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, the following: the impact of
macroeconomic conditions, including significant global inflation and elevated interests rates, legislative developments, trade disruptions and the potential adverse effects of current geopolitical conditions; business disruptions due to natural
disasters, acts of terrorism, pandemics, riots, civil insurrection or social unrest, looting, protests, strikes or street demonstrations; changes in operational and reimbursement processes and payment structures at the state or federal levels;
changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates, and the timeliness of reimbursements received under government programs; changes in, or our failure to comply with existing, federal
and state laws or regulations or our failure to comply with new government laws or regulations on a timely basis; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and
payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system
reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and
retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to the
overall economic conditions and deficit reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our
ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches,
cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of
the markets for our services, including our expectations regarding the market for our services; eligibility standards and limits on services imposed by state governmental agencies; the potential for litigation, audits and investigations;
discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating and integrating acquisition opportunities, and expand
into new geographic markets; the impact of acquisitions and dispositions , including the potential inability to realize the benefits of potential acquisitions on our business; the effectiveness, quality and cost of our services; our ability to
successfully execute our growth strategy; changes in tax rates; the impact of inclement weather or natural disasters; and various other matters, and other risks set forth in the section titled &#147;Risk Factors&#148; in our&nbsp;periodic reports
filed with the SEC, including, but not limited to, the our&nbsp;Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023, and our other filings with the SEC, including the preliminary
prospectus supplement and the final </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADUS Announces Pricing of Public Offering of Common Stock </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;26, 2024 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
prospectus supplement (when available). We caution readers not to place undue reliance on any such forward-looking statements which speak only as of the date made. Except as required by law, we
undertake no obligation to update or revise any forward-looking statements that it makes in its press releases, whether as a result of new information, future events or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-END- </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>adus-20240626.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/28/2024 5:27:59 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:adus="http://www.addus.com/20240626"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.addus.com/20240626"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adus-20240626_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adus-20240626_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>adus-20240626_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/28/2024 5:27:59 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>adus-20240626_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 6/28/2024 5:27:59 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="adus-20240626.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g805293dsp006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805293dsp006.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M"LG3?TZ^HJYTW!V9,)J:NC>219%#(RLIZ$'(J#0?0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ':@#A?
MB?K7]F^&3:1OB>^;RQCJ$'+'^GXUVX.ESU/0\_&U>2%NYYYX+O\ #36#GK^\
MC_J/Y&NS&TK+G.7 5KOD9W%O<SVK;K>9XS_LGC\J\AH]FYM6OBF:/"W4(D']
MY.#^72E8#<L]7L[TA8I@'/\  W!I#+X.1Q0 4 % !0 F: %% !0 4 )F@ H
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M=\59)F\7['SL2W3RQ['.?UKV\ DHMK<\''-\ZN>F>$XM#D\/VJZ8EN\7E@.
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M,\=^%*N?&2E>@MWW?3C^M>MC?X21XV!UJNQ[E7BGO/8\&\9?\E+G_P"N\/\
M):]RC_NQX%;^.>\I]T5XC/>CL-E*K$Q;[H'-$=Q3TB>!>"_WGQ$LC!]WSW88
M_NX:O<KZ8;4\&AKB=#Z %>$?0GCOQA_Y#>G?]<&_]"KU\!\#/$Q_QH])\*?\
MBGI/_7M'_P"@BO-K?Q&>GA_X:)O$?_(M:I_UZR?^@FII?&BJ_P##9Y5\(?\
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M@C!%,#@[S39[:\EB2&1T5OE8*2".U,1#]DN?^?:7_O@TP$-I<X_X]Y?^^#2
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M9[DHLS*,!?+P#T/>@#9Q0 M !0 4 % !0 4 % !0 F * %H 2@ P.M "T %
M!0 4 % !0 4 % !0 4 5S:PGS@4_UW^L_P!KC'\J )5C58U0#"J, 4 54TJS
MCE$BP@%3D#)VJ?4#H* +$T*31-%(NY#U% $7V* LS&,;F<.Q]6'0T 23P1W,
M)BF7<AZCI0 EM:16H81 @-R<L3_.@".XTZVNGWRQY;&"0Q&1Z''6@"1[>-[<
MP%/W1&TJ../2@ :VA9HF,8W1'*$<8XQ0 KP1R/&[KEHSE3Z'&* "&".WCV1+
@L7).!V)H A73;5)_.6,B3=NR&/7Z9H N4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g805293g0626210403025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g805293g0626210403025.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  E 50# 2(  A$! Q$!_\0
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M?5?BOX;LKJ[:T@FB*O.K;2@SUS7O5<AXM^&V@>-+Z&\U9;@RPIL7RY-HQ^5
M'B/C#P_I?@K5-$U/2/$!UBZ6Z4"WG<2<>O6OIBVD:6UBD9=K.@8KZ$CI7"Z+
M\&_!^B:C'?0V<LTT1W)Y\FX*?7%=\!@8H ^=?'FCVFN_'7[#>ZDVG0/: FX5
MMI7 /&:]=\$1:/H6CP:'9Z['J$BLS*S2AG;-5?$WPI\-^+-8;5-36Y-PR!#Y
M<N!@>V*9X=^$?ACPOK,.JZ<ER+F($+OER.?;% ';7'_'M+_N'^5?,'@_2_&5
MS;^)KWPQJXM(K:Z=I81]Z0@D\?A7U$ZAT93T(P:P/#/@W2O":WRZ:LN+V7S9
M?,;=D_Y- 'F?P(L8-0.I^);N]EN=:DD,,XDZH/7\:]EO?^0?<?\ 7)OY&L#0
M/ FC^&M9OM3TP3127I)ECWY3.<\"NDDC66)XF^ZZE3]#0!\N^#]-\:OX=UW4
M_#.K_9K:VN)&DMU^\Y&>1^%=]\!M/M;FRO\ Q%+>27.L7,ICN?,ZICG]:](\
M,^#]*\)V=U:Z:LGE7,IED$C;LD]?PJ'PYX&T?PKJ%[>:6)HS>-NEC9\IG.>!
MVH Z">".Y@>&5 \<BE74]"#UKYZ\'>#;%?C=J&DR.\MCI3M<6\+?=#$\<>U?
M15<]8>#=*T[Q7>^(X!+]OO%VRDOE<>PH Z#&*Y/Q%H5Y<7C7Z7[K L; QGHG
M'45UM(P#*5(R#U%7";@[HRJTE5CRL\K\/:%<ZC;R+:ZG@I.&9E)^7'I[UZA!
M&T,$:.Y<JN"QZFH+'3;738FBM8PBLQ8@>IJWC(JZ]9U97,L+AE0C;J><?$W2
MO!VOW&GZ=K^IK8:B<FUE#891[^U>=6<^K_#KQ]HNF6'B;^V=/OI51X0^[:I.
M.?0]Z]G\5^ M \91H-6M2TL8PDT9VNH],UD^&/A%X6\+:BNH6L$T]TG^KDN'
MW;/H,=:Q.H[L=*\8^'7_ "6_QO\ [Y_]#->S@8KG])\&:3HWB/4==M%E%[J!
MS.6?*]<\"@#H#7R/8V=W8#5/&.G FZT;6,NOK&WK[9X_&OKFN4TSX>:#I6GZ
MO8PQ2O;ZJ2;E9'SG/IZ4 ?.XTVY_MCPGXDU#)O-<U4W+9[)YB[?YDU]9?PBN
M8U7P#H>KS:-)<12+_9!!M5C? 7!!&?7[HKIR.,4 >.>-/"W@OQ7XON1%XA&E
M^((57SBCX#''&??I5+X7:[K>G?$6_P#!]WJXUBPBA:1+@-N"D8Z'\<?6NX\4
M?";PMXJOFOKNVD@NV^_+;MM+^Y'K6CX1^'^@>"DD.DV[":48DFE;<[#TSZ4
M;2:Q8//)"MRGF1YWKGICK_(U8MKJ*[@6:%MR-T.*SI?#EC(2RAXV=W:1E/+[
M\[@?;DUH6EL+2W6$2/)MZ,YR: )Z*** $HS110 9HS110 9HS110 9HS110
M9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HS1
M10 9HHHH *,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:,T44 &:*
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140431271195024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Addus HomeCare Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001468328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 26,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-5340172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6303 Cowboys Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Frisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(469)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">535-8200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADUS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -JKVU@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #:J]M8F:Z$%N\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9)1
M2\,P$,>_BN2]O335(:'+BV-/"H(#Q;>0W+9@DX;DI-VWMZU;A^@'\#%W__SN
M=W"-B=)T"9]3%S&1PWPS^#9D:>*:'8FB!,CFB%[G<DR$L;GODM<T/M,!HC8?
M^H @.%^!1])6DX8)6,2%R%1CC30)-77IC+=FP<?/U,XP:P!;]!@H0U56P-0T
M,9Z&MH$K8((1)I^_"V@7XES]$SMW@)V30W9+JN_[LJ_GW+A#!6]/CR_SNH4+
MF70P./[*3M(IXII=)K_6#YO=EBG!Q6W!5X6XW_%*UES>B??)]8??5=AWUNW=
M/S:^"*H&?MV%^@)02P,$%     @ VJO;6)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M@JXN#^9EPZJL. POE86C=7&YX0RF@7L ?E\I9=\;[GQ=_3TR_@=02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ VJO;6"0>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ VJO;6 =!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " #:J]M8F:Z$%N\    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( -JKVU@<.&7J/P$  #P"   /
M  "  680  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #:J]M8)!Z;HJT
M  #X 0  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #:J]M899!YDAD!  #/ P  $P
M@ &W$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   !%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d805293d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d805293d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File>adus-20240626.xsd</File>
    <File>adus-20240626_lab.xml</File>
    <File>adus-20240626_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d805293d8k.htm">d805293d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d805293d8k.htm": {
   "nsprefix": "adus",
   "nsuri": "http://www.addus.com/20240626",
   "dts": {
    "schema": {
     "local": [
      "adus-20240626.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "adus-20240626_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adus-20240626_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d805293d8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-06-26_to_2024-06-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d805293d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-06-26_to_2024-06-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d805293d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.addus.com//20240626/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-24-170947-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-170947-xbrl.zip
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M#-WIA":A\3..W;RNMC95!KC^NM6V1JN%M:G)Q4&J0RIOOZ=II=^M'4V#INU
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M,RI.?/SD0(CJ$GS1M@/Y/VR%7$5[J;G# OO(Z_J(?;,/<&+)7U!+ P04
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MJ2OC_(@HO5%Q"1+%U36ZJ=!'4S0F1P;$M_20A&()1&7./WBC=BK(*.(S%66
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M3> /W@,_\?D\K>!#/^U]GO> +-AQO\3OS3+'(YSO?Z8X'MY#9&_^8?=Y0$E
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MX'[5E67A7F)W= +G?)VE];0"_B@LM+7%PL/&(\>ZE5I#\?#.3,!+">#C.H&
M6W7UD)9X&239_O=T]-1S'*QW1LK12'D9V"NQ>W!.XY'Y+="JW6@2&*C/Z1ZR
M4!G8PJBS@_@%+),$Y[+*X!K+BQVIR4*\2 ;1-TM!RN'%2_/R\KI[F?B=["<9
M<_E!99/)L3"(V[1,Q]%5"(2,%VE2.*&<;]YIN\Y;;&I(EJ_HW=<DR/&H?Q>-
MFC#/JKKAS1$&&'@/8%G U.;H=4'V5??S+XV6P<%WQR8[/+E(LCR9  ^0C0K>
MTF*]\,@B!1NB OM6S5JU)ZJN (D.?WC@V3+880%?WH^<5Z!NN0/Z+U9,MVJ
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MFP7'VLZ&&A<1DS<$F-9XM"ZC2A3H@=BEYW2.KX8L!Z]OC[/CP8.=V9K<<W8
MIVRCTH:AO3D<!T4&,@7#>^8=T0-69M=Y?+WEG7NO(X?=VXN-K[]:8K4)>S1=
MV=.$7)>P-G%2PO19"I'/@>A2N7J8;2IF1^VV+C ZUAJ<[?W:F&X7E/G _419
MR<D4O0X'D/=H@HITS],S]E=S^H2[!JQDD@K):3Y#87.OI'(=_,QHH)PD-*G1
M[X\U$0UQ#]"PRM79N1BBL"VI^D/Q$UL+M:G"P2G$LS*MNW:9C8%;Z4[GC#H-
MO*A!(M)_V^/B3_P6ME0'3C';PI\4I,BKKM?OM%@5.08K.IJ*7D34W$#/227M
M5,L*Y0CH9[C#^^@U0L_"7-2'VZ>5"C5X5X=+$35CM+4\]!^&RAQ+2)\>WH4*
MP&/3VQ?W7;0X..*8SJ=<,7O@=%N?*%K48KKT*):QOB9FWVKEDJWC=6DBPJF<
M)(O9K42ZY"REBMUN6N^@>NX-NF&K_ N:97=JC9$ELM:\O0]?XJSE2VQ UUTI
MNWFK OLWW2"CF,#SSZ_"OYFH>T+?I,.\L\G>&,RK@L)K#OXL,V$2^*C1<[0.
MGTUT!Y@10HD$;KF.4Z0G1:C+7>T0'+  (@QWQ?!9!ZCQ_%E,:^R[KN[WU@<=
M?B$96;+;CAQO!P4A1A8P\^U\^KTWL&M=47[=D"92I1=9>BD+%083R/\.E^EA
ML.6ZO/W[N"3I+MI"2N4?+9E0F;XO3>]D#P0)@DY.P;JN,/B%$:-_(2-/"1)/
M]LV[FT.EZ1Z2\G'U<\LB),SUKZ3G-CB8EIX<BA9IN@2!]E:03$9%B71D)?#Q
M*,1 "':5(@XD94C!6K^'47*68$H"V*57WGN$+QU^0ZS*/:+_9#/44NE%*-%S
M]'\EV4S2(@K$80#AX11$THS:RQFN1T6V  HA!E#%3T2YK!02AQTC##RX-/Q?
M+BM%50%6L*HY+80O?0W:4YY4^B#*.E SR9%!.\SK9:R(OG#$?=RR,TMG;THP
M?+RH#W@73/XMK?*#K/(]K;*/[KS[B5,KQ(RH6L,-;1J1*5*-8+Y0''4"1^3M
M"QZ*-H_28/!XO2$R[-+4:@M5(I2I8_@ES!!M$V/JE5=2:66Z2>=67288X[^?
MPSP/#]-K$,>S"U3104V@*&HW:.F"?AX?9,8QSJW,B4%785]TVMM>JDJ(N8F7
M#0VU6C1/J<4P-@><R1EF3UUW2H&YTYW3SX%"5*5>9A2E5PP2WL2((]'.C3T#
M/2@OE\+7T%8O5SDF]F/^"]PC"J)B@L%4A#*L=I53$7TR/#A\ZR"16&DJ%,C,
MU[98/!=V.D@Z3U)AUE =CT<*U<3@<&G%N%TEH]W U8P%GB<.L7E\E75-;)ZN
M*H;XT)JM,@K5< @!H\O)E*,8>JNJ&5N1TW)5<8J(GT:8:\:^_*8FHE!$H=A8
M+D0*!2P)]!3F!0Y?"(?A*5^U1T5G-(ZQ6N &<P3%3G3];:?EIQ5CBR#'!]O_
M3 (UIBS#(0I(:@)[_:W[10$Y:EO#W;Z4D=Y)EZORI*4P7W.OQB/>K-@[U8'O
MK2I&S+GR-*<GSNXDMT@DOEE6I>C#X?_B][AEL#ZZ7MZSHX8N.@XXED6O +Y1
M,QD18)?FN:@RG57?K*/^X=^.^EM"J"AV'+$/T*12%*Y+#/\2<\O+$E7SI&K.
M_U@EGY'"D^F4#!6O-$R3/%D0B;=X$V9OB_X)"N>J0@V0.*.@A<"-!>OO,WR6
M)Q-4++)ZB:8@$?BJHE><X1B%Y/@RQX@E4HRAS5DZ!3X1,Z]/R*_ ]XGOS44V
M6R6HH'IV[+ QXW:D\7K<CY5;=ZGI4$D\2W S8'%\[3?QXR=JGW?EGPO&D3[L
MF 8M/ZE=TMHT668-U5DB*IK(1&-,^Z=I]\'B:/8(CP(>S<OBC/] K6<"S-CF
M19LTW?8>J0QOB6K:_;3@U+N6 P%'^IR1D3+-V9%')@2Z+#'*W,8]K$!X&J5/
MAZ[Y5ZUS]-IL<) $ ]<63IJ1&:Q'^";,C-<?[*I3-:K4V0_D&IQIUFYG\OK>
MSL;)3O2_Z)YL75%%,_FO56)/85A,7<?;?SP%^H5+V5<Q\*[*INDE4AV(HSH]
M*5'#0<31=[$+,+NP?<J7KEQFA;IXQB/103V<2T\!\8YD>"#%)K5#3VMI#V)D
M:,XL*QEPFSQ\&><<8<8#W 9*X7!5R<.!+"E-'4@A)1U#2L/O4C6.)4,V,P=A
MK"^)BR1\-*05(H"*V'O!CCJ>9P)C0K=]V=:T>2N#P_*.7Z7#'/M7OD4]BMS!
MS\NDFIDLX'<GQV^?=[ +OSJ!_QZ$HAUEN5/I]][TDN!MZ&,\N@F!K#?G(O$L
M1O,DJ];E+XH14Y=YQK!6?GG+4@!JV[9!4&I5DWB=)NJP$\,13"E]#-1*:]BP
M6HX_P]0[8&_G93[S'F;Q+I#/-*G/4?.XK%UT"O/!2^#V+B.=\[9Z[VS;JS#@
M?[C.3H4Y3&OR+@5V<0CO %;>-V/OLW!!Y9Z$*E#VT<./KL(I"D+<>'_KEA6L
M.UOF;*Y3C-9OP:<BP\=I\;5%JCT^?A<4$,O/D'XU]PGW:))@/;+$9%TD3<XD
M*R[*_((]N*UD99>8)=F6;D*]?)C/E$R4Q+D?$BJ[^F^81DU)%L]587V?ZD:^
M!L):@>;N3YY]2S=)[U=RT'+$;EB74<#FK$_VDPSKA;54?]DS[<M]\$Q#=1&/
M1W"VRM"+6Z0V[![N%VLZGN)HSU#!K5R=FU%$!.#V+K9J(V]2>*0!YA0/;F#<
MV76,(A=ZR41<PSVCM3J5$R-9Q(^)?)EF#1%[!*6^VRES,RG4RM4F9?E9T2'P
M]/HT8H<;3.BE[J3"TAV7@.!<JAW;7[P]QL71;_0CN+I#*RVV* 0HY_.]"9AI
M<*I: %"?(]29]::(HLKLX0(T5*(V!?EFLP=F*!E.W;HXJHCQ M7H!!\0.#S!
MO6.= (&M*]AR<5(X?-V'CW=CC0O>T-VYML CM@%!(B&[\X1!8_:#_8=DUSB7
M3;\11RM7*XZJ3MO7TI":I-=VQ !:KRWILITLNR;<"L-XS%S13&UR5:[+#DR=
MYV;@CAX,R;7I7'AYN7!V,X$79;''XHRIV^\\$">O,H!^O#(J;1OY93#_RT%Y
MV@*H7<W;TK)J&2?Z9:!&BX8YA4V+#@\H><O_9(NRO7]L*N!I)6D!#^HM073U
MQK$/#0&QES:3B*JEF2HF"6/-D^>&?:M@LY;3C,B$R[<WFR*<)B@O 3&0,Z7;
M#22_!!Q=TRZ0XFJ_!P<' 3*/'"29%C'CD8-6G8$JI/I& +.>$(()J2\DEC6&
MRT8],-1&(=@= 9E*D3KNO[G.X= 2PVO,@YL:B.OU_V\WY?K1WY[<N[9S/[?A
M'\*,)/B0>4'X66WD-G!W0AWJ-8BMUS25TKV.@XMRQ_")SVFZ[%&EG-L6&,4*
M1<YZK7H!4HHSW:*:9D8OQ4,HR#OLF U56I0YSF8^!VX@X4W!,/+A0#3%Q3%-
M<_EY//+!1^O Q3FZ#)4>31YV'4A.D:B1P8J]1N*>S=:I2_*@:QX$EMKOX@UB
MGW.0C<<%H"WVU:]H]!B1*"(CZ5NDFPD:J_CR)/Y$0!L4AWQBG=%H=M8,GL4]
M1$"_]N6H5$!S=QMS82)N?B^&YDGXS$B/E?+;]$_I9J/]3AISZ C) 31SD>2B
MB2PQ'%MEE HYU=AV [1;=)QGI,EG<X>!1AY[.]O[-6#72HQ>4,^[LGBS.OJ"
MINZ]> KS_BIS6(=P%YSX.T2!F:&&^21ZD3*SF6:I%OF=B-\+2.=4&97\GERE
MQF!R%-'FM^.19;CD.X=K#@H695);QE@;O=XS07QBZ:;9KIO=7$6.AR2 50^2
MO<-'JH+BN!M_??AH9G[2KQ+O:ES ,=^DHCJ?&@0HZXAI06LB@6$"6OW%A4;?
MM?%Q[F=GO)YA@$A[=S%D2C]RA_C9X-TL#0AY!$6,5")DC7W&)(?(,Q/!S:^]
M_8QH06I;Q^P5SJ9@$>"MA -3+X[WM_G25OD0D^V)=HPS?\CVJ#0U0B^K%4/>
M$XF8@ROE/9Z'MWT?R!5"&"7O)J;07V^P;5'6#,""SB"@5U2R_UC!NM.J$P(E
MP>M*7H?=M*5+$B'M?56(,)V7W=)J<WOVHP^9X!!O.6&Q$F3BT56:5+&+?NKV
M@4F%I(NR#<V7F>4+%./D^8]'EZ"BTKX)5V^]V.DV<I<CC(8;LJJ<$-EIQ=ZQ
M.HBJDP7-#,M/F0QN^R:Z@N?DY>55H$N:3L@66[E\*X0-SJ600)\'040_B&\U
MD]"])JFCW*E3 ZMNQ51\=/TEEE/Q^\A%Q&&ZU!L)\6ZS-1C;7+LWT=ULS7UD
M/"["8+%METK^X%^P^OJ#-A$<A@GLV!AAUGB@&HGJH6G)1N^C&(:? 1#!&;[?
M-3'T'#)/+AW7^AT.N@:.JIIU%@ ):6A/VPVXB43+\E)$0*(P2'BN($F I^>4
M=4'^10J)I2(G- =057+,*UQA2Q_$/%-%D:1UJQC\CL*%\EHR8S5S93:8;:<;
M%N"RMN\@G1#<AYSB='#1\1S0 @=V&)P'RE>Q>LQ:^30[9X4Z--J8P>DX24B>
M7'GGU.6FJBCT:4FD1N/E<[4TEV"*U.?9DO)?X"NA2SF9*W6>ZKD$N9,Z)X):
MDM@7>XO)1XCN+=)8.$Y8^DV19*1PA9RGRIR[+U=URWPFF\XZD-MX3\IT89E#
MV+*R#[1)@/>-$'7*VI5IZ< 5C92TU$618]UT/%JGG>X='*EN>FU?['_OFI\&
ML7+C$Z$KZ=MU1G;IT0X#L,AJ/[17R"5$_7CC=AP-X 9\$JW<$ "MK,Z2@JMM
M^F#"MF6EU :ZL3<'\TW3F4EAG3KPRK!@^,Z8L%]-ARF#"MW#BW<\JU9W[:XR
MZ.@ORI]#3*R6+A#0D3!>4J-S5_';RWAO<7I_89:-<?;;\NSH+\RRCWTC9E_B
M-1[9ILR=W$^.2?BZ';]U0>/F=)C& E_N<,$:DD"[+HP@#=?4AO'UK/A VR5J
M&O6F7?MVD=\?_QW4N%UZNL) A'X:"AJ3:(3[7ZFM)P5IOBMY#)9:U9PE&.)<
M2J@SSQ"K! SQU6+"7G_T(6NU3YYD"YLA %=RGER4E=Z..BTRXCJ% )7U7!DG
M9C!N6 $# H:"&0&%*WE<>V=;G=5=IK;3#!@ADED ?'F1E;F+ I@RR;)3R]?>
M)LZ_<Z@0_@T#62OH$Y,D%+ \@QOJ2E3R*VD^$L@;#10'E89:0N1W>R<Q7O2
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MGS;"&*)3-JX_J)?WF$WRPY]^>,AU70M"9S+=2HUZ0HZ9E>+EATJ@>(&DBWS
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M=X 5:VXHVJF?+[5/-3-IQKO1#7F?"M@PQ<N0WF],C?=DH\WG(68P+*1N,).
MELO0O'NBG$8ODB;IE9ZU_QT% <LS6.LY-J+&-/J->\()^7NBL.K62+=GZ>%\
MM^6R%07E^"YCR3A0)19B<()6N:I<C,\2I62>U:+PPG0SWWI'H*@5:1=QHZC
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ME[Z=)VST"=%QO\2?E2E'\AR.>VG&=6U!R==!PSC8$)*;R*=\HU946V-!]%*
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M>C>A3SS]<YEY_"J0$7BMM!6.IU_6RVG</+%GYQH5/W]&<[J7_4B#MFMM^W?
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M2UJ<EWE>7M8_KUG[D+YQM]DY)[Z#P*N,6D&\2M-ZH C3)=^ #B;L4RH0_3#
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M;L0\N.;T\%;8@5]F8\9EY2=VB:$35[!$?27P0'($'2Z*M.JR(#SKV)7\#B*
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MS2$%I3 %ZB\7H+)46?T9)PFV&/SD/%MN,^-8@(%S*2Q1/Y&+U]$<) B;N3X
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MI6BZ6&O"P&7R1.^HPL)-&/1F;)O=U44IG54-3ALS /E8E1>Z7.VX:N?J^<6
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M)^+G,J4U;6O(:SRPZD">&?^JJ%RB"NA,V%6B<PG2(P,]6Q-^KFL_&.WBM'#
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M&.2I$X&\G;BFBIC+FI!CN]-PS&+Z"S:W8MU"NMSUX["2S82F58@;%\#R:,T
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MT5L$0Z4_WY($SJ3)6QNAA_PZK?X;+KKY2OV*G)TM/:IFFZ$'V9X8*H_?5NG
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M1.ADB1IU)_.DA?M'B<XX3F"V?.T+#MMK&$.- H86>]PS5<R7)@242QD9 #_
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M:7RU.A=\#M1N;:MXC3DU*.Q$$B-@<2/!FN"&0#C]I-")<+)1"1<E&P/2=BN
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MADH9Z.4HZPLN.V5R8-X6]M(D!?/2:> *U?:@'.VZ@7*XF$$%O,P:W/1L-*Y
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M2N^32^@BUY3/<O&-6$F-SZYQ#9P&(&3 "]8DT&6,A]S9'([U3F 1-2S $FS
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M5T%UMM98_ 6#/B"_G&5!AVYE9\"L'0MV.@R!,:EOK3E3P$=))M-*8TTADM-
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MZ?*@ZB"@T 5DH7GX)7C$@%CJ:V;W-C7CUK3,D\N8&INX7+9)].=46<4(:#X
M.KH)G(<BAC'NA WM )O"!1!6@#1.<D-98WE "=\?W_%F=46/>:S'&TU1.#^V
M&\43W*PHCO\5=@ES@*A%/TWU@8; /B<O_52Y.4;JZ1BJ 2].S%&V*8P[/;=-
MT!8ZA3"\'^/,-=@7(-)H.5$I2GW^K'TU/99@]S"<O"&$IMW5WPH3LQ6Z^Y]0
M5981HTI91925O8@K3RVBJ1*M*B/$<J5B:$FIFQG#70V4C4]3/@#8,'A8S%M8
MVU:BYS!F^4"B0")QY?9@-MI3W6TT^]4+@90,#12C_Z3@TE19,P/$GVR+'H@(
M'OW@M%)DV_D"=;Z?ITF%(.8#Q',WI$AE.5%K6# (P%5B%2 HX7Y6]:<C\(7Z
M= ;O]'/M7@XAK6OF0B8["D-@\VO'TV$^H^P*;??.,5N0-+ 45I )_AK^7]!H
M5RTY&Z$<#7LD7$XGQK?T  49U?WZUD=++T.V2.2;(JLKB]LB#VJ S)4"(P$B
M^--BL4!O\+PU,&PQ,Q@**0)G236S/I>L1>BIJ$TQ9MQLRPJ4J^4OB8P.U05I
M@M-6K/I<#S/F..'FLL(PR2$+GHIMG#Y[LMGKK_4VUY3T]W;79A^1B4V+VJ(4
M-8A%'1@U5XU*_42;;02=F[>%",%8['3^<V,OH;P!^T6(OR!#QZF8'K ;AJW;
M#D>3O,F$B<_J"3* 3'@E,I$)*U.3N"*&!>XP0ZK,+_01I=W$3(:E<L^3Z>2\
MK"@J8"/@_*FR<JW5B25;+"LWFC6AQ(<XZ U+9],Q5LCYC07;C+\A7N^%]S3G
MF: (X_G UHB)-1U#DL)<;+N:A&3QM)!F([POAR2+&F!V67=)T5SB6U!P,5(Z
M@9,B-:U*YI;.7/&;^*;=[%,JKFGW*2WT;/,-1@^U&6D(ZA<T!K]]4Q \S[NP
M!:,YIJ"U,"JQ*Z]W-4^WEJ^;Y'6I727-DRHY6]2_.22JFF M:[%'-U,1V?56
MBL)$],\T&9D^PZ@,F;ATV^;&G,_3/!BQ".2<Z@" DZ0"1QRH M'\ ^I%%#T@
MT7+98,.FT3WD4?H3Q)#;?I*L3MY+,'Y RIW^B$RRGXTTN<ESZKZ83S4HW4B?
M:R#]I=*EY&YQA&*0&AYG4(!36HWL;['E"S: 4CS_,=$.U95LS-S#ABVI$H2.
MQOCWDKV!Y"GI0U1;,RDUS[6:V<3ZO(S& ?^:G3E(6X;9"JFK#S"[3AJTR69N
MRX@^3RXH&=;8F^060VI]6MA8DSA,2 9(95E 4AD\W7@G1*GZ<)RPNB(F'>/H
MS13.]@SCT I$@02%HB0EU;F42OV391$CF8W:.O! <)@5:@%F<%G:>O!2Y=5
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MKC;/D+CS.:"C$N%_=DA,)7F@(92]_[D5%VI,#)[4LLC!%C_G&E/8M2T'8_.
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MSRD)V.96%X7*1%Z.$AWAE[&RX9:=UFZWV^IVN\)-(=O1-:1-"O614=%MI?7
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MTB(W^I9;66O@^K0%L <!ASGP*T@[*1L!>0,L6Q753-\P6I<9;1E[-:9@+P!
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M3:.BLC2/BK5535<L49'<@A690?G''@E6(@436X6?AQ*^!R2"7O/VIQ.<PN[
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M,C R-# V,C8N>'-D4$L! A0#%     @ VJO;6&YG97J !@  N48  !4
M         ( !; ,  &%D=7,M,C R-# V,C9?;&%B+GAM;%!+ 0(4 Q0    (
M -JKVUA:KOADQ 0  #DL   5              "  1\*  !A9'5S+3(P,C0P
M-C(V7W!R92YX;6Q02P$"% ,4    " #:J]M8]:48L,04  !^@   #@
M        @ $6#P  9#@P-3(Y,V0X:RYH=&U02P$"% ,4    " #:J]M8!F\2
M].>O  !'M@, $               @ $&)   9#@P-3(Y,V1E>#$Q+FAT;5!+
M 0(4 Q0    ( -JKVUB#F#;<,@H  $<A   0              "  1O4  !D
M.# U,CDS9&5X-3$N:'1M4$L! A0#%     @ VJO;6.2!L3UK$0  ZC0  !$
M             ( !>]X  &0X,#4R.3-D97@Y.3$N:'1M4$L! A0#%     @
MVJO;6*CD4 +O$0  ;SD  !$              ( !%?   &0X,#4R.3-D97@Y
<.3(N:'1M4$L%!@     (  @ ^P$  #," 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>d805293d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adus-20240626.xsd" xlink:type="simple"/>
    <context id="duration_2024-06-26_to_2024-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-06-26_to_2024-06-26"
      id="Hidden_dei_EntityRegistrantName">Addus HomeCare Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-316">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-06-26_to_2024-06-26"
      id="Hidden_dei_EntityCentralIndexKey">0001468328</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-327">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-328">2024-06-26</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-329">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-330">001-34504</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-331">20-5340172</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-332">6303 Cowboys Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-333">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-334">Frisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-335">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-336">75034</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-337">(469)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-338">535-8200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-339">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-340">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-341">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-342">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-343">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-344">ADUS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-345">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-06-26_to_2024-06-26" id="ixv-346">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
